BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC, Sperling L, Virani SS, Yeboah J. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139:e1082-e1143. [PMID: 30586774 DOI: 10.1161/cir.0000000000000625] [Cited by in Crossref: 250] [Cited by in F6Publishing: 310] [Article Influence: 62.5] [Reference Citation Analysis]
Number Citing Articles
1 Isakadze N, Mehta PK, Law K, Dolan M, Lundberg GP. Addressing the Gap in Physician Preparedness To Assess Cardiovascular Risk in Women: a Comprehensive Approach to Cardiovascular Risk Assessment in Women. Curr Treat Options Cardiovasc Med 2019;21:47. [PMID: 31359165 DOI: 10.1007/s11936-019-0753-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Cavero-Redondo I, Deeks JJ, Alvarez-Bueno C, Jolly K, Saz-Lara A, Price M, Pascual-Morena C, Martínez-Vizcaíno V. Comparative effect of physical exercise versus statins on improving arterial stiffness in patients with high cardiometabolic risk: A network meta-analysis. PLoS Med 2021;18:e1003543. [PMID: 33591983 DOI: 10.1371/journal.pmed.1003543] [Reference Citation Analysis]
3 Jurcau A, Simion A. Cognition, Statins, and Cholesterol in Elderly Ischemic Stroke Patients: A Neurologist's Perspective. Medicina (Kaunas) 2021;57:616. [PMID: 34199243 DOI: 10.3390/medicina57060616] [Reference Citation Analysis]
4 Pavlović J, Greenland P, Franco OH, Kavousi M, Ikram MK, Deckers JW, Ikram MA, Leening MJG. Recommendations and Associated Levels of Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: A Comparison at Population Level of the American Heart Association/American College of Cardiology/Multisociety, US Preventive Services Task Force, Department of Veterans Affairs/Department of Defense, Canadian Cardiovascular Society, and European Society of Cardiology/European Atherosclerosis Society Clinical Practice Guidelines. Circ Cardiovasc Qual Outcomes 2021;14:e007183. [PMID: 34546786 DOI: 10.1161/CIRCOUTCOMES.120.007183] [Reference Citation Analysis]
5 Kim EJ, Wierzbicki AS. The history of proprotein convertase subtilisin kexin-9 inhibitors and their role in the treatment of cardiovascular disease. Ther Adv Chronic Dis 2020;11:2040622320924569. [PMID: 32537117 DOI: 10.1177/2040622320924569] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Lopez-Vilaret KM, Cantero JL, Fernandez-Alvarez M, Calero M, Calero O, Lindín M, Zurrón M, Díaz F, Atienza M. Impaired glucose metabolism reduces the neuroprotective action of adipocytokines in cognitively normal older adults with insulin resistance. Aging (Albany NY) 2021;13:23936-52. [PMID: 34731089 DOI: 10.18632/aging.203668] [Reference Citation Analysis]
7 White Z, Hakim CH, Theret M, Yang NN, Rossi F, Cox D, Francis GA, Straub V, Selby K, Panagiotopoulos C, Duan D, Bernatchez P. High prevalence of plasma lipid abnormalities in human and canine Duchenne and Becker muscular dystrophies depicts a new type of primary genetic dyslipidemia. J Clin Lipidol 2020;14:459-469.e0. [PMID: 32593511 DOI: 10.1016/j.jacl.2020.05.098] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
8 Sanchez RJ, Ge W, Wei W, Ponda MP, Rosenson RS. The association of triglyceride levels with the incidence of initial and recurrent acute pancreatitis. Lipids Health Dis 2021;20:72. [PMID: 34275452 DOI: 10.1186/s12944-021-01488-8] [Reference Citation Analysis]
9 Suero-Abreu GA, Karatasakis A, Rashid S, Tysarowski M, Douglas A, Patel R, Siddiqui E, Bhardwaj A, Gerula CM, Matassa D. Factors Associated with Disparities in Appropriate Statin Therapy in an Outpatient Inner City Population. Healthcare (Basel) 2020;8:E361. [PMID: 32987753 DOI: 10.3390/healthcare8040361] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Maile MD, Sigakis MJ, Stringer KA, Jewell ES, Engoren MC. Impact of the pre-illness lipid profile on sepsis mortality. J Crit Care 2020;57:197-202. [PMID: 32182565 DOI: 10.1016/j.jcrc.2020.01.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
11 Ritchey MD, Wall HK, George MG, Wright JS. US trends in premature heart disease mortality over the past 50 years: Where do we go from here? Trends Cardiovasc Med 2020;30:364-74. [PMID: 31607635 DOI: 10.1016/j.tcm.2019.09.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
12 Dayoub EJ, Eberly LA, Nathan AS, Khatana SAM, Adusumalli S, Navar AM, Giri J, Groeneveld PW. Adoption of PCSK9 Inhibitors Among Patients With Atherosclerotic Disease. J Am Heart Assoc 2021;10:e019331. [PMID: 33904340 DOI: 10.1161/JAHA.120.019331] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Martins AMA, Paiva MUB, Paiva DVN, de Oliveira RM, Machado HL, Alves LJSR, Picossi CRC, Faccio AT, Tavares MFM, Barbas C, Giraldez VZR, Santos RD, Monte GU, Atik FA. Innovative Approaches to Assess Intermediate Cardiovascular Risk Subjects: A Review From Clinical to Metabolomics Strategies. Front Cardiovasc Med 2021;8:788062. [PMID: 35004898 DOI: 10.3389/fcvm.2021.788062] [Reference Citation Analysis]
14 Lee SH, Kim MK, Rhee EJ. Effects of Cardiovascular Risk Factor Variability on Health Outcomes. Endocrinol Metab (Seoul) 2020;35:217-26. [PMID: 32615706 DOI: 10.3803/EnM.2020.35.2.217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Cheng HS, Tan WR, Low ZS, Marvalim C, Lee JYH, Tan NS. Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence. Int J Mol Sci. 2019;20. [PMID: 31614690 DOI: 10.3390/ijms20205055] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 15.3] [Reference Citation Analysis]
16 Petersen KS, Davis KM, Rogers CJ, Proctor DN, West SG, Kris-Etherton PM. Herbs and spices at a relatively high culinary dosage improves 24-hour ambulatory blood pressure in adults at risk of cardiometabolic diseases: a randomized, crossover, controlled-feeding study. Am J Clin Nutr 2021:nqab291. [PMID: 34510174 DOI: 10.1093/ajcn/nqab291] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Bolognese MA, Franco CB, Ferrari A, Bennemann RM, Lopes SMA, Bertolini SMMG, Júnior NN, Branco BHM. Group Nutrition Counseling or Individualized Prescription for Women With Obesity? A Clinical Trial. Front Public Health 2020;8:127. [PMID: 32426316 DOI: 10.3389/fpubh.2020.00127] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Hjell G, Mørch-Johnsen L, Holst R, Tesli N, Bell C, Lunding SH, Rødevand L, Werner MCF, Melle I, Andreassen OA, Lagerberg TV, Steen NE, Haukvik UK. Disentangling the relationship between cholesterol, aggression, and impulsivity in severe mental disorders. Brain Behav 2020;10:e01751. [PMID: 32681586 DOI: 10.1002/brb3.1751] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 O'Donnell CJ. Opportunities, challenges and expectations management for translating biobank research to precision medicine. Eur J Epidemiol 2020;35:1-4. [PMID: 32107740 DOI: 10.1007/s10654-020-00616-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Khan TZ, Schatz U, Bornstein SR, Barbir M. Hypertriglyceridaemia: contemporary management of a neglected cardiovascular risk factor. Glob Cardiol Sci Pract 2021;2021:e202119. [PMID: 34805377 DOI: 10.21542/gcsp.2021.19] [Reference Citation Analysis]
21 Peng AW, Dardari ZA, Blumenthal RS, Dzaye O, Obisesan OH, Iftekhar Uddin SM, Nasir K, Blankstein R, Budoff MJ, Bødtker Mortensen M, Joshi PH, Page J, Blaha MJ. Very High Coronary Artery Calcium (≥1000) and Association With Cardiovascular Disease Events, Non-Cardiovascular Disease Outcomes, and Mortality: Results From MESA. Circulation 2021;143:1571-83. [PMID: 33650435 DOI: 10.1161/CIRCULATIONAHA.120.050545] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
22 Cornelissen A, Jinnouchi H, Sakamoto A, Torii S, Kuntz S, Guo L, Fernandez R, Paek K, Mayhew C, Kutyna M, Romero ME, Kolodgie FD, Virmani R, Finn AV. Evaluation and Management of the Vulnerable Plaque. Curr Cardiovasc Risk Rep 2019;13. [DOI: 10.1007/s12170-019-0606-0] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Hauspurg A, Countouris ME, Catov JM. Hypertensive Disorders of Pregnancy and Future Maternal Health: How Can the Evidence Guide Postpartum Management? Curr Hypertens Rep 2019;21:96. [PMID: 31776692 DOI: 10.1007/s11906-019-0999-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
24 Yuan S, Tang B, Zheng J, Larsson SC. Circulating Lipoprotein Lipids, Apolipoproteins and Ischemic Stroke. Ann Neurol 2020;88:1229-36. [PMID: 32981134 DOI: 10.1002/ana.25916] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
25 Park J, Lee SH, Han S, Oh AR, Lee SK, Choi GS, Park MS, Carriere K, Ahn J, Kim GS. An observational study on the effect of hypercholesterolemia developed after living donor liver transplantation on cardiac event and graft failure. Sci Rep 2021;11:959. [PMID: 33441656 DOI: 10.1038/s41598-020-79673-5] [Reference Citation Analysis]
26 Trpkov C, Savtchenko A, Liang Z, Feng P, Southern DA, Wilton SB, James MT, Feil E, Mylonas I, Miller RJH. Visually estimated coronary artery calcium score improves SPECT-MPI risk stratification. Int J Cardiol Heart Vasc 2021;35:100827. [PMID: 34195354 DOI: 10.1016/j.ijcha.2021.100827] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Finch ER, Payton MA, Jenkins DA, Cai X, Li L, Karol SE, Relling MV, Janke LJ. Fenofibrate reduces osteonecrosis without affecting antileukemic efficacy in dexamethasone-treated mice. Haematologica 2021;106:2095-101. [PMID: 32675219 DOI: 10.3324/haematol.2020.252767] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
28 Shah NS, Siddique J, Huffman MD, Kanaya AM, Kandula NR. Cardiovascular health and subclinical atherosclerosis in second generation South Asian Americans: The MASALA study. Indian Heart J 2021;73:629-32. [PMID: 34627581 DOI: 10.1016/j.ihj.2021.07.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Kang SH, Baek H, Cho J, Kim S, Hwang H, Lee W, Park JJ, Yoon YE, Yoon CH, Cho YS, Youn TJ, Cho GY, Chae IH, Choi DJ, Yoo S, Suh JW. Management of cardiovascular disease using an mHealth tool: a randomized clinical trial. NPJ Digit Med 2021;4:165. [PMID: 34862449 DOI: 10.1038/s41746-021-00535-z] [Reference Citation Analysis]
30 Jia X, Koh S, Al Rifai M, Blumenthal RS, Virani SS. Spotlight on Icosapent Ethyl for Cardiovascular Risk Reduction: Evidence to Date. Vasc Health Risk Manag 2020;16:1-10. [PMID: 32021223 DOI: 10.2147/VHRM.S210149] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
31 Yannas D, Frizza F, Vignozzi L, Corona G, Maggi M, Rastrelli G. Erectile Dysfunction Is a Hallmark of Cardiovascular Disease: Unavoidable Matter of Fact or Opportunity to Improve Men's Health? J Clin Med 2021;10:2221. [PMID: 34065601 DOI: 10.3390/jcm10102221] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Byker Shanks C, Vanderwood K, Grocke M, Johnson N, Larison L, Wytcherley B, Yaroch AL. The UnProcessed Pantry Project (UP3): A Community-Based Intervention Aimed to Reduce Ultra-Processed Food Intake Among Food Pantry Clients. Fam Community Health 2022;45:23-33. [PMID: 34783688 DOI: 10.1097/FCH.0000000000000310] [Reference Citation Analysis]
33 Bae JH, Moon MK, Oh S, Koo BK, Cho NH, Lee MK. Validation of Risk Prediction Models for Atherosclerotic Cardiovascular Disease in a Prospective Korean Community-Based Cohort. Diabetes Metab J 2020;44:458-69. [PMID: 31950769 DOI: 10.4093/dmj.2019.0061] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
34 Jiang J, Mao S, Xie Y, Chen X, Abulaiti K, Liu M, Zheng J, Hu W, Hou Z, Chen L, Xiang H. Is residential greenness associated with dyslipidemia and lipid levels in Chinese rural-dwelling adults? The Henan rural cohort study. Environ Sci Pollut Res Int 2021. [PMID: 34426868 DOI: 10.1007/s11356-021-16026-3] [Reference Citation Analysis]
35 Garcia E, Bennett DW, Connelly MA, Jeyarajah EJ, Warf FC, Shalaurova I, Matyus SP, Wolak-Dinsmore J, Oskardmay DN, Young RM, Sampson M, Remaley AT, Otvos JD. The extended lipid panel assay: a clinically-deployed high-throughput nuclear magnetic resonance method for the simultaneous measurement of lipids and Apolipoprotein B. Lipids Health Dis 2020;19:247. [PMID: 33261644 DOI: 10.1186/s12944-020-01424-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
36 Chen L, Vavrenyuk A, Ren JH, Desai P, Bahgat J, Bernstein MA, Ebright MI, Gowda M, Rose S, Fallahi A, Stainken B, Hsi DH. Prognostic Value of Coronary Artery Calcification Identified by the Semi-quantitative Weston Method in the Emergency Room or Other Hospitalized Patients. Front Cardiovasc Med 2021;8:684292. [PMID: 34222379 DOI: 10.3389/fcvm.2021.684292] [Reference Citation Analysis]
37 Li PY, Chen RY, Wu FZ, Mar GY, Wu MT, Wang FW. Use of Coronary Computed Tomography Angiography to Screen Hospital Employees with Cardiovascular Risk Factors. Int J Environ Res Public Health 2021;18:5462. [PMID: 34065262 DOI: 10.3390/ijerph18105462] [Reference Citation Analysis]
38 Sunil B, Ashraf AP. Dyslipidemia in Pediatric Type 2 Diabetes Mellitus. Curr Diab Rep 2020;20:53. [PMID: 32909078 DOI: 10.1007/s11892-020-01336-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
39 Steffens D, Bramlage P, Scheeff C, Kasner M, Hassanein A, Friebel J, Rauch-Kröhnert U. PCSK9 inhibitors and cardiovascular outcomes. Expert Opin Biol Ther 2020;20:35-47. [PMID: 31593483 DOI: 10.1080/14712598.2020.1677604] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
40 Ong KL, McClelland RL, Allison MA, Cushman M, Garg PK, Tsai MY, Rye KA, Tabet F. Lipoprotein (a) and coronary artery calcification: prospective study assessing interactions with other risk factors. Metabolism 2021;116:154706. [PMID: 33421505 DOI: 10.1016/j.metabol.2021.154706] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
41 Deng F, Li D, Lei L, Yang Q, Li Q, Wang H, Deng J, Zheng Q, Jiang W. Association between apolipoprotein B/A1 ratio and coronary plaque vulnerability in patients with atherosclerotic cardiovascular disease: an intravascular optical coherence tomography study. Cardiovasc Diabetol 2021;20:188. [PMID: 34526013 DOI: 10.1186/s12933-021-01381-9] [Reference Citation Analysis]
42 Anderson H, Sweeney C, Perry R, Vaquero J, Ison H. Patient-Centered Team-Based Learning in Pre-Clinical Curriculum Supporting the Application of Knowledge to Real-World Clinical Experience. Med Sci Educ 2020;30:65-8. [PMID: 34457639 DOI: 10.1007/s40670-019-00872-5] [Reference Citation Analysis]
43 Singh K, Thanassoulis G, Dufresne L, Nguyen A, Gupta R, Narayan KV, Tandon N, Sniderman A, Prabhakaran D. A Comparison of Lipids and apoB in Asian Indians and Americans. Glob Heart. 2021;16:7. [PMID: 33598387 DOI: 10.5334/gh.882] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Quispe R, Michos ED, Martin SS, Puri R, Toth PP, Al Suwaidi J, Banach M, Virani SS, Blumenthal RS, Jones SR, Elshazly MB. High-Sensitivity C-Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study. J Am Heart Assoc 2020;9:e013600. [PMID: 32013698 DOI: 10.1161/JAHA.119.013600] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
45 Wang H, Liu Z, Shao J, Lin L, Jiang M, Wang L, Lu X, Zhang H, Chen Y, Zhang R. Immune and Inflammation in Acute Coronary Syndrome: Molecular Mechanisms and Therapeutic Implications. J Immunol Res 2020;2020:4904217. [PMID: 32908939 DOI: 10.1155/2020/4904217] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
46 Shiffman D, Louie JZ, Devlin JJ, Knowles JW, McPhaul MJ. Gaps in Dyslipidemia Care Among Working-Aged Individuals With Employer-Sponsored Health Care. J Am Heart Assoc 2020;9:e015807. [PMID: 32319337 DOI: 10.1161/JAHA.119.015807] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
47 Gogineni VSM, Manfrini D, Aroda SH, Zhang Y, Nelson DS, Egerman R, Park K. Variations in Awareness of Association Between Adverse Pregnancy Outcomes and Cardiovascular Risk by Specialty. Cardiol Ther 2021. [PMID: 34043209 DOI: 10.1007/s40119-021-00220-y] [Reference Citation Analysis]
48 Orkaby AR, Driver JA, Ho YL, Lu B, Costa L, Honerlaw J, Galloway A, Vassy JL, Forman DE, Gaziano JM, Gagnon DR, Wilson PWF, Cho K, Djousse L. Association of Statin Use With All-Cause and Cardiovascular Mortality in US Veterans 75 Years and Older. JAMA 2020;324:68-78. [PMID: 32633800 DOI: 10.1001/jama.2020.7848] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 17.0] [Reference Citation Analysis]
49 Shiffman D, Louie JZ, Devlin JJ, Rowland CM, Mora S. Concordance of Cardiovascular Risk Factors and Behaviors in a Multiethnic US Nationwide Cohort of Married Couples and Domestic Partners. JAMA Netw Open 2020;3:e2022119. [PMID: 33104207 DOI: 10.1001/jamanetworkopen.2020.22119] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
50 Santos LP, Umpierre D. Exercise, Cardiovascular Health, and Risk Factors for Atherosclerosis: A Narrative Review on These Complex Relationships and Caveats of Literature. Front Physiol 2020;11:840. [PMID: 32848823 DOI: 10.3389/fphys.2020.00840] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
51 Izkhakov E, Shacham Y, Serebro M, Yaish I, Marcus Y, Shefer G, Tordjman K, Greenman Y, Stern N, Ziv-Baran T. The Effect of the PCSK9 Inhibitor Evolocumab on Aldosterone Secretion among High Cardiovascular Risk Patients: A Pilot Study. J Clin Med 2021;10:2504. [PMID: 34198795 DOI: 10.3390/jcm10112504] [Reference Citation Analysis]
52 Im J, Kawada-Watanabe E, Yamaguchi J, Arashi H, Otsuki H, Matsui Y, Sekiguchi H, Fujii S, Mori F, Ogawa H, Hagiwara N. Baseline low-density lipoprotein cholesterol predicts the benefit of adding ezetimibe on statin in statin-naïve acute coronary syndrome. Sci Rep 2021;11:7480. [PMID: 33820931 DOI: 10.1038/s41598-021-87098-x] [Reference Citation Analysis]
53 Marston NA, Bonaca MP, Jarolim P, Goodrich EL, Bhatt DL, Steg PG, Cohen M, Storey RF, Johanson P, Wiviott SD, Braunwald E, Sabatine MS, Morrow DA. Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines. JAMA Cardiol 2020;5:1255-62. [PMID: 32756916 DOI: 10.1001/jamacardio.2020.2981] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
54 Derington CG, King JB, Bryant KB, McGee BT, Moran AE, Weintraub WS, Bellows BK, Bress AP. Cost-Effectiveness and Challenges of Implementing Intensive Blood Pressure Goals and Team-Based Care. Curr Hypertens Rep 2019;21:91. [PMID: 31701259 DOI: 10.1007/s11906-019-0996-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
55 Appiah LT, Sarfo FS, Nguah SB, Huffman MD, Stiles JK, Feinstein MJ. Lipoprotein(a) and High Sensitivity C-Reactive Protein among Patients with HIV in Ghana: The Study on Cardiovascular Risk Profile of HIV-Infected Patients on HAART (SCRIPT). Glob Heart 2020;15:74. [PMID: 33299770 DOI: 10.5334/gh.850] [Reference Citation Analysis]
56 Cobos-Palacios L, Sanz-Cánovas J, Muñoz-Ubeda M, Lopez-Carmona MD, Perez-Belmonte LM, Lopez-Sampalo A, Gomez-Huelgas R, Bernal-Lopez MR. Statin Therapy in Very Old Patients: Lights and Shadows. Front Cardiovasc Med 2021;8:779044. [PMID: 34912868 DOI: 10.3389/fcvm.2021.779044] [Reference Citation Analysis]
57 Rodriguez A, Trigatti BL, Mineo C, Knaack D, Wilkins JT, Sahoo D, Asztalos BF, Mora S, Cuchel M, Pownall HJ, Rosales C, Bernatchez P, Ribeiro Martins da Silva A, Getz GS, Barber JL, Shearer GC, Zivkovic AM, Tietge UJF, Sacks FM, Connelly MA, Oda MN, Davidson WS, Sorci-Thomas MG, Vaisar T, Ruotolo G, Vickers KC, Martel C. Proceedings of the Ninth HDL (High-Density Lipoprotein) Workshop: Focus on Cardiovascular Disease. Arterioscler Thromb Vasc Biol 2019;39:2457-67. [PMID: 31597448 DOI: 10.1161/ATVBAHA.119.313340] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
58 Schwartz GG, Szarek M, Bittner VA, Bhatt DL, Diaz R, Goodman SG, Jukema JW, Loy M, Manvelian G, Pordy R, White HD, Steg PG; ODYSSEY OUTCOMES Committees and Investigators. Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment. Diabetes Care 2021;44:1219-27. [PMID: 33722880 DOI: 10.2337/dc20-2842] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
59 Nanna MG, Navar AM, Wojdyla D, Nelson AJ, Sullivan AE, Peterson ED. Can the Absence of Hypertension Refine the Risk Assessment of Older Adults for Future Cardiovascular Events? Am J Cardiol 2021;142:83-90. [PMID: 33279483 DOI: 10.1016/j.amjcard.2020.11.027] [Reference Citation Analysis]
60 Veronesi G, Baldwin DR, Henschke CI, Ghislandi S, Iavicoli S, Oudkerk M, De Koning HJ, Shemesh J, Field JK, Zulueta JJ, Horgan D, Fiestas Navarrete L, Infante MV, Novellis P, Murray RL, Peled N, Rampinelli C, Rocco G, Rzyman W, Scagliotti GV, Tammemagi MC, Bertolaccini L, Triphuridet N, Yip R, Rossi A, Senan S, Ferrante G, Brain K, van der Aalst C, Bonomo L, Consonni D, Van Meerbeeck JP, Maisonneuve P, Novello S, Devaraj A, Saghir Z, Pelosi G. Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe. Cancers (Basel) 2020;12:E1672. [PMID: 32599792 DOI: 10.3390/cancers12061672] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
61 Vikulova DN, Skorniakov IS, Bitoiu B, Brown C, Theberge E, Fordyce CB, Francis GA, Humphries KH, Mancini GBJ, Pimstone SN, Brunham LR. Lipid-lowering therapy for primary prevention of premature atherosclerotic coronary artery disease: Eligibility, utilization, target achievement, and predictors of initiation. Am J Prev Cardiol 2020;2:100036. [PMID: 34327459 DOI: 10.1016/j.ajpc.2020.100036] [Reference Citation Analysis]
62 Koo BK, Chung WY, Moon MK. Peripheral arterial endothelial dysfunction predicts future cardiovascular events in diabetic patients with albuminuria: a prospective cohort study. Cardiovasc Diabetol 2020;19:82. [PMID: 32534580 DOI: 10.1186/s12933-020-01062-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Gobbel GT, Matheny ME, Reeves RR, Akeroyd JM, Turchin A, Ballantyne CM, Petersen LA, Virani SS. Leveraging structured and unstructured electronic health record data to detect reasons for suboptimal statin therapy use in patients with atherosclerotic cardiovascular disease. Am J Prev Cardiol 2022;9:100300. [PMID: 34950914 DOI: 10.1016/j.ajpc.2021.100300] [Reference Citation Analysis]
64 van der Ploeg MA, Floriani C, Achterberg WP, Bogaerts JMK, Gussekloo J, Mooijaart SP, Streit S, Poortvliet RKE, Drewes YM. Recommendations for (Discontinuation of) Statin Treatment in Older Adults: Review of Guidelines. J Am Geriatr Soc 2020;68:417-25. [PMID: 31663610 DOI: 10.1111/jgs.16219] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
65 Borén J, Chapman MJ, Krauss RM, Packard CJ, Bentzon JF, Binder CJ, Daemen MJ, Demer LL, Hegele RA, Nicholls SJ, Nordestgaard BG, Watts GF, Bruckert E, Fazio S, Ference BA, Graham I, Horton JD, Landmesser U, Laufs U, Masana L, Pasterkamp G, Raal FJ, Ray KK, Schunkert H, Taskinen MR, van de Sluis B, Wiklund O, Tokgozoglu L, Catapano AL, Ginsberg HN. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 2020;41:2313-30. [PMID: 32052833 DOI: 10.1093/eurheartj/ehz962] [Cited by in Crossref: 188] [Cited by in F6Publishing: 153] [Article Influence: 188.0] [Reference Citation Analysis]
66 Wong ND, Cordola Hsu AR, Rozanski A, Shaw LJ, Whelton SP, Budoff MJ, Nasir K, Miedema MD, Rumberger J, Blaha MJ, Berman DS. Sex Differences in Coronary Artery Calcium and Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in Adults With Diabetes: The Coronary Calcium Consortium. Diabetes Care 2020;43:2597-606. [PMID: 32816996 DOI: 10.2337/dc20-0166] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
67 Weng Y, Yin R, Qian L, Chen Z, Wang J, Xiang H, Xue Y, Ji K, Guan X. Low-Density Lipoprotein Cholesterol is Inversely Associated with All-Cause Mortality of Patients in the Coronary Care Unit. Int J Gen Med 2021;14:7659-67. [PMID: 34764679 DOI: 10.2147/IJGM.S332755] [Reference Citation Analysis]
68 Furlanetto ML Jr, Chagas EFB, Slm P. Atherosclerotic Extension of Carotid Arteries: An Insertion in Clinical Practice. Int J Vasc Med 2020;2020:3120327. [PMID: 32655952 DOI: 10.1155/2020/3120327] [Reference Citation Analysis]
69 Schwalm JD, McCready T, Lear SA, Lamelas P, Garis L, Musa H, Vincent K, Islam S, Attaran A, McKee M, Yusuf S. Exploring New Models for Cardiovascular Risk Reduction: The Heart Outcomes Prevention and Evaluation 4 (HOPE 4) Canada Pilot Study. CJC Open 2021;3:267-75. [PMID: 33778443 DOI: 10.1016/j.cjco.2020.10.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Lopez T, Nuffer W. Impact and Sustainability of a 10-year Community Pharmacy Disease Management Service. Innov Pharm 2021;12. [PMID: 34007665 DOI: 10.24926/iip.v12i1.3630] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Lee SH. We can do much better than what we did. Korean J Intern Med 2020;35:547-9. [PMID: 32392662 DOI: 10.3904/kjim.2020.130] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
72 Patel J, Mehta A, Rifai MA, Blaha MJ, Nasir K, McEvoy JW, Pandey A, Kanaya AM, Kandula NR, Virani SS, Abbate A, Hundley G, Sperling L, Joshi PH. Hypertension guidelines and coronary artery calcification among South Asians: Results from MASALA and MESA. Am J Prev Cardiol 2021;6:100158. [PMID: 34327495 DOI: 10.1016/j.ajpc.2021.100158] [Reference Citation Analysis]
73 Liou L, Kaptoge S. Association of small, dense LDL-cholesterol concentration and lipoprotein particle characteristics with coronary heart disease: A systematic review and meta-analysis. PLoS One 2020;15:e0241993. [PMID: 33166340 DOI: 10.1371/journal.pone.0241993] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
74 Song JW, Nam HS, Ahn JW, Park HS, Kang DO, Kim HJ, Kim YH, Han J, Choi JY, Lee SY, Kim S, Oh WY, Yoo H, Park K, Kim JW. Macrophage targeted theranostic strategy for accurate detection and rapid stabilization of the inflamed high-risk plaque. Theranostics 2021;11:8874-93. [PMID: 34522216 DOI: 10.7150/thno.59759] [Reference Citation Analysis]
75 Nicholls SJ, Nissen SE, Prati F, Windecker S, Kataoka Y, Puri R, Hucko T, Kassahun H, Liao J, Somaratne R, Butters J, Di Giovanni G, Jones S, Psaltis PJ. Assessing the impact of PCSK9 inhibition on coronary plaque phenotype with optical coherence tomography: rationale and design of the randomized, placebo-controlled HUYGENS study. Cardiovasc Diagn Ther 2021;11:120-9. [PMID: 33708484 DOI: 10.21037/cdt-20-684] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
76 Lumsden RH, Pagidipati N. Management of cardiovascular risk factors during pregnancy. Heart. [DOI: 10.1136/heartjnl-2021-319606] [Reference Citation Analysis]
77 Wang H, Jiang M, Li X, Zhao Y, Shao J, Liu Z, Lin L, Xu Q, Wang L, Lu X, Zhang H, Chen Y, Zhang R. Anti-inflammatory Therapies for Coronary Heart Disease: A Systematic Review and Meta-Analysis. Front Cardiovasc Med 2021;8:726341. [PMID: 34513960 DOI: 10.3389/fcvm.2021.726341] [Reference Citation Analysis]
78 Brown RE, Welsh P, Logue J. Systematic review of clinical guidelines for lipid lowering in the secondary prevention of cardiovascular disease events. Open Heart 2020;7:e001396. [PMID: 33443127 DOI: 10.1136/openhrt-2020-001396] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Bozkurt B, Hershberger RE, Butler J, Grady KL, Heidenreich PA, Isler ML, Kirklin JK, Weintraub WS. 2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure). Circ Cardiovasc Qual Outcomes 2021;14:e000102. [PMID: 33755495 DOI: 10.1161/HCQ.0000000000000102] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
80 Riveros-Mckay F, Weale ME, Moore R, Selzam S, Krapohl E, Sivley RM, Tarran WA, Sørensen P, Lachapelle AS, Griffiths JA, Saffari A, Deanfield J, Spencer CCA, Hippisley-Cox J, Hunter DJ, O'Sullivan JW, Ashley EA, Plagnol V, Donnelly P. Integrated Polygenic Tool Substantially Enhances Coronary Artery Disease Prediction. Circ Genom Precis Med 2021;14:e003304. [PMID: 33651632 DOI: 10.1161/CIRCGEN.120.003304] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
81 Semb AG, Ikdahl E, Wibetoe G, Crowson C, Rollefstad S. Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis. Nat Rev Rheumatol 2020;16:361-79. [PMID: 32494054 DOI: 10.1038/s41584-020-0428-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 10.5] [Reference Citation Analysis]
82 Sampson M, Wolska A, Warnick R, Lucero D, Remaley AT. A New Equation Based on the Standard Lipid Panel for Calculating Small Dense Low-Density Lipoprotein-Cholesterol and Its Use as a Risk-Enhancer Test. Clin Chem 2021;67:987-97. [PMID: 33876239 DOI: 10.1093/clinchem/hvab048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
83 Chen L, Huang Y, Yu H, Pan K, Zhang Z, Man Y, Hu D. The association of parameters of body composition and laboratory markers with the severity of hypertriglyceridemia-induced pancreatitis. Lipids Health Dis 2021;20:9. [PMID: 33573658 DOI: 10.1186/s12944-021-01443-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Reyes-Soffer G, Ginsberg HN, Berglund L, Duell PB, Heffron SP, Kamstrup PR, Lloyd-Jones DM, Marcovina SM, Yeang C, Koschinsky ML; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; and Council on Peripheral Vascular Disease. Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association. Arterioscler Thromb Vasc Biol 2022;42:e48-60. [PMID: 34647487 DOI: 10.1161/ATV.0000000000000147] [Reference Citation Analysis]
85 Murphy E, Curneen JMG, McEvoy JW. Aspirin in the Modern Era of Cardiovascular Disease Prevention. Methodist Debakey Cardiovasc J 2021;17:36-47. [PMID: 34824680 DOI: 10.14797/mdcvj.293] [Reference Citation Analysis]
86 Greco MF, Sirtori CR, Corsini A, Ezhov M, Sampietro T, Ruscica M. Lipoprotein(a) Lowering-From Lipoprotein Apheresis to Antisense Oligonucleotide Approach. J Clin Med 2020;9:E2103. [PMID: 32635396 DOI: 10.3390/jcm9072103] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
87 Domenech M, Casas R, Ruiz-León AM, Sobrino J, Ros E, Estruch R. Effects of a Novel Nutraceutical Combination (Aquilea Colesterol®) on the Lipid Profile and Inflammatory Biomarkers: A Randomized Control Trial. Nutrients 2019;11:E949. [PMID: 31035469 DOI: 10.3390/nu11050949] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
88 Jung J, Bae GH, Kang M, Kim SW, Lee DH. Statins and All-Cause Mortality in Patients Undergoing Hemodialysis. J Am Heart Assoc 2020;9:e014840. [PMID: 32089045 DOI: 10.1161/JAHA.119.014840] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
89 Sinning D, Landmesser U. Low-density Lipoprotein-Cholesterol Lowering Strategies for Prevention of Atherosclerotic Cardiovascular Disease: Focus on siRNA Treatment Targeting PCSK9 (Inclisiran). Curr Cardiol Rep 2020;22:176. [PMID: 33089390 DOI: 10.1007/s11886-020-01427-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
90 Goldberg RB. Clinical Approach to Assessment and Amelioration of Atherosclerotic Vascular Disease in Diabetes. Front Cardiovasc Med 2020;7:582826. [PMID: 33134327 DOI: 10.3389/fcvm.2020.582826] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
91 Szafraniec-Szczęsny J, Antosik-Rogóż A, Kurek M, Gawlak K, Górska A, Peralta S, Knapik-Kowalczuk J, Kramarczyk D, Paluch M, Jachowicz R. How Does the Addition of Kollidon®VA64 Inhibit the Recrystallization and Improve Ezetimibe Dissolution from Amorphous Solid Dispersions? Pharmaceutics 2021;13:147. [PMID: 33498609 DOI: 10.3390/pharmaceutics13020147] [Reference Citation Analysis]
92 Drobni ZD, Murphy SP, Alvi RM, Lee C, Gong J, Mosarla RC, Rambarat PK, Hartmann SB, Gilman HK, Zubiri L, Raghu VK, Sullivan RJ, Zafar A, Zlotoff DA, Sise ME, Guidon AC, Reynolds KL, Dougan M, Neilan TG. Association between incidental statin use and skeletal myopathies in patients treated with immune checkpoint inhibitors. Immunother Adv 2021;1:ltab014. [PMID: 34541581 DOI: 10.1093/immadv/ltab014] [Reference Citation Analysis]
93 Grau-Perez M, Caballero-Mateos MJ, Domingo-Relloso A, Navas-Acien A, Gomez-Ariza JL, Garcia-Barrera T, Leon-Latre M, Soriano-Gil Z, Jarauta E, Cenarro A, Moreno-Franco B, Laclaustra M, Civeira F, Casasnovas JA, Guallar E, Tellez-Plaza M. Toxic Metals and Subclinical Atherosclerosis in Carotid, Femoral, and Coronary Vascular Territories: The Aragon Workers Health Study. Arterioscler Thromb Vasc Biol 2022;42:87-99. [PMID: 34879710 DOI: 10.1161/ATVBAHA.121.316358] [Reference Citation Analysis]
94 Świątkiewicz I, Di Somma S, De Fazio L, Mazzilli V, Taub PR. Effectiveness of Intensive Cardiac Rehabilitation in High-Risk Patients with Cardiovascular Disease in Real-World Practice. Nutrients 2021;13:3883. [PMID: 34836144 DOI: 10.3390/nu13113883] [Reference Citation Analysis]
95 Sinnaeve PR, Schwartz GG, Wojdyla DM, Alings M, Bhatt DL, Bittner VA, Chiang CE, Correa Flores RM, Diaz R, Dorobantu M, Goodman SG, Jukema JW, Kim YU, Pordy R, Roe MT, Sy RG, Szarek M, White HD, Zeiher AM, Steg PG; ODYSSEY OUTCOMES Investigators. Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis.Eur Heart J. 2020;41:2248-2258. [PMID: 31732742 DOI: 10.1093/eurheartj/ehz809] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 18.0] [Reference Citation Analysis]
96 Brooks DC, Schindler JL. Management of Hyperlipidemia After Stroke. Curr Treat Options Cardiovasc Med 2019;21:93. [PMID: 31840196 DOI: 10.1007/s11936-019-0774-8] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
97 Barrett PM. Editorial: Adverse Pregnancy Outcomes-A Missed Opportunity to Prevent Chronic Disease? Int J Public Health 2021;66:582810. [PMID: 34366764 DOI: 10.3389/ijph.2021.582810] [Reference Citation Analysis]
98 Chen CY, Wu WT, Wang YL, Liao KM. Statins for the Treatment of Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease. Front Pharmacol 2020;11:613761. [PMID: 33510638 DOI: 10.3389/fphar.2020.613761] [Reference Citation Analysis]
99 Ward NC, Kostner KM, Sullivan DR, Nestel P, Watts GF. Molecular, Population, and Clinical Aspects of Lipoprotein(a): A Bridge Too Far? J Clin Med 2019;8:E2073. [PMID: 31783529 DOI: 10.3390/jcm8122073] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
100 Gutierrez JA, Aday AW, Patel MR, Jones WS. Polyvascular Disease: Reappraisal of the Current Clinical Landscape.Circ Cardiovasc Interv. 2019;12:e007385. [PMID: 31833412 DOI: 10.1161/CIRCINTERVENTIONS.119.007385] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
101 Jeon-Slaughter H, Chen X, Ramanan B, Tsai S. Assessing Performance of the Veterans Affairs Women Cardiovascular Risk Model in Predicting a Short-Term Risk of Cardiovascular Disease Incidence Using United States Veterans Affairs COVID-19 Shared Data. Int J Environ Res Public Health 2021;18:10005. [PMID: 34639306 DOI: 10.3390/ijerph181910005] [Reference Citation Analysis]
102 Lee CK, Liao CW, Meng SW, Wu WK, Chiang JY, Wu MS. Lipids and Lipoproteins in Health and Disease: Focus on Targeting Atherosclerosis. Biomedicines 2021;9:985. [PMID: 34440189 DOI: 10.3390/biomedicines9080985] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
103 Manfredini E, Alves RJ. Unusual Finding of Rare Exuberant Xanthomatosis in Hyperlipidemia. Arq Bras Cardiol 2021;117:407-10. [PMID: 34495241 DOI: 10.36660/abc.20200999] [Reference Citation Analysis]
104 Ko HHT, Lareu RR, Dix BR, Hughes JD, Parsons RW. A sequence symmetry analysis of the interrelationships between statins, diabetes and skin infections. Br J Clin Pharmacol 2019;85:2559-67. [PMID: 31595525 DOI: 10.1111/bcp.14077] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
105 Ober AJ, Takada S, Zajdman D, Todd I, Horwich T, Anderson A, Wali S, Ladapo JA. Factors affecting statin uptake among people living with HIV: primary care provider perspectives. BMC Fam Pract 2021;22:215. [PMID: 34717560 DOI: 10.1186/s12875-021-01563-0] [Reference Citation Analysis]
106 Liu Y, Wang W, Song J, Zhang K, Xu B, Li P, Shao C, Yang M, Chen J, Tang YD. Association Between Lipoprotein(a) and Peri-procedural Myocardial Infarction in Patients With Diabetes Mellitus Who Underwent Percutaneous Coronary Intervention. Front Endocrinol (Lausanne) 2020;11:603922. [PMID: 33613445 DOI: 10.3389/fendo.2020.603922] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
107 Ma L, Wang A, Zhang Y, Wang Y, Wang Y, Meng X. Associations Between Polyvascular Disease and Stroke Recurrence in Patients With Lacunar Stroke. Front Neurol 2021;12:706991. [PMID: 34566851 DOI: 10.3389/fneur.2021.706991] [Reference Citation Analysis]
108 Langslet G, Hovingh GK, Guyton JR, Baccara-Dinet MT, Letierce A, Manvelian G, Farnier M. Regional Variations in Alirocumab Dosing Patterns in Patients with Heterozygous Familial Hypercholesterolemia During an Open-Label Extension Study. Cardiovasc Drugs Ther 2020;34:515-23. [PMID: 32363493 DOI: 10.1007/s10557-020-06984-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
109 Handhle A, Viljoen A, Wierzbicki AS. Elevated Lipoprotein(a): Background, Current Insights and Future Potential Therapies. Vasc Health Risk Manag 2021;17:527-42. [PMID: 34526771 DOI: 10.2147/VHRM.S266244] [Reference Citation Analysis]
110 Lepe A, de Kroon MLA, de Winter AF, Reijneveld SA. Alternative pediatric metabolic syndrome definitions impact prevalence estimates and socioeconomic gradients. Pediatr Res 2021. [PMID: 33446919 DOI: 10.1038/s41390-020-01331-3] [Reference Citation Analysis]
111 Esposito A, Francone M, Andreini D, Buffa V, Cademartiri F, Carbone I, Clemente A, Guaricci AI, Guglielmo M, Indolfi C, La Grutta L, Ligabue G, Liguori C, Mercuro G, Mushtaq S, Neglia D, Palmisano A, Sciagrà R, Seitun S, Vignale D, Pontone G, Carrabba N. SIRM-SIC appropriateness criteria for the use of Cardiac Computed Tomography. Part 1: Congenital heart diseases, primary prevention, risk assessment before surgery, suspected CAD in symptomatic patients, plaque and epicardial adipose tissue characterization, and functional assessment of stenosis. Radiol Med 2021;126:1236-48. [PMID: 34160775 DOI: 10.1007/s11547-021-01378-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 Wu P, Park K, Gulati M. The Fourth Trimester: Pregnancy as a Predictor of Cardiovascular Disease. Eur Cardiol 2021;16:e31. [PMID: 34603511 DOI: 10.15420/ecr.2021.18] [Reference Citation Analysis]
113 Jafari L, Akhter N. Heart failure prevention and monitoring strategies in HER2-positive breast cancer: a narrative review. Breast Cancer Res Treat 2021;186:295-303. [PMID: 33481134 DOI: 10.1007/s10549-021-06096-9] [Reference Citation Analysis]
114 Taron J, Lyass A, Mahoney TF, Ehrbar RQ, Vasan RS, D'Agostino RB Sr, Hoffmann U, Massaro JM, Lu MT. Coronary Artery Calcium Score-Directed Primary Prevention With Statins on the Basis of the 2018 American College of Cardiology/American Heart Association/Multisociety Cholesterol Guidelines. J Am Heart Assoc 2021;10:e018342. [PMID: 33348999 DOI: 10.1161/JAHA.120.018342] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
115 Paluch AE, Gabriel KP, Fulton JE, Lewis CE, Schreiner PJ, Sternfeld B, Sidney S, Siddique J, Whitaker KM, Carnethon MR. Steps per Day and All-Cause Mortality in Middle-aged Adults in the Coronary Artery Risk Development in Young Adults Study. JAMA Netw Open 2021;4:e2124516. [PMID: 34477847 DOI: 10.1001/jamanetworkopen.2021.24516] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
116 Okada S, Morimoto T, Ogawa H, Soejima H, Matsumoto C, Sakuma M, Nakayama M, Doi N, Jinnouchi H, Waki M, Masuda I, Saito Y. Association Between Statins and Cancer Incidence in Diabetes: a Cohort Study of Japanese Patients with Type 2 Diabetes. J Gen Intern Med 2021;36:632-9. [PMID: 33063203 DOI: 10.1007/s11606-020-06167-5] [Reference Citation Analysis]
117 Guo Y, Wheldon CW, Shao H, Pepine CJ, Handberg EM, Shenkman EA, Bian J. Statin Use for Atherosclerotic Cardiovascular Disease Prevention Among Sexual Minority Adults. J Am Heart Assoc 2020;9:e018233. [PMID: 33317368 DOI: 10.1161/JAHA.120.018233] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
118 Navar AM, Mulder HM, Wojdyla DM, Peterson ED. Have the Major Cardiovascular Outcomes Trials Impacted Payer Approval Rates for PCSK9 Inhibitors? Circ Cardiovasc Qual Outcomes 2020;13:e006019. [PMID: 31918581 DOI: 10.1161/CIRCOUTCOMES.119.006019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
119 Mora S, Martin SS, Virani SS. Cholesterol Insights and Controversies From the UK Biobank Study. Circulation 2019;140:553-5. [PMID: 31403842 DOI: 10.1161/CIRCULATIONAHA.119.042134] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
120 Patel AP, Wang M, Kartoun U, Ng K, Khera AV. Quantifying and Understanding the Higher Risk of Atherosclerotic Cardiovascular Disease Among South Asian Individuals: Results From the UK Biobank Prospective Cohort Study. Circulation 2021;144:410-22. [PMID: 34247495 DOI: 10.1161/CIRCULATIONAHA.120.052430] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
121 Lai J, Han Y, Huang C, Li B, Ni J, Dong M, Wang Y, Wang Q. Non-invasive skin cholesterol testing: a potential proxy for LDL-C and apoB serum measurements. Lipids Health Dis 2021;20:137. [PMID: 34657601 DOI: 10.1186/s12944-021-01571-0] [Reference Citation Analysis]
122 Moorman AJ, Dean LS, Yang E, Drezner JA. Cardiovascular Risk Assessment in the Older Athlete. Sports Health 2021;13:622-9. [PMID: 33733939 DOI: 10.1177/19417381211004877] [Reference Citation Analysis]
123 Patel AP, Wang M, Fahed AC, Mason-Suares H, Brockman D, Pelletier R, Amr S, Machini K, Hawley M, Witkowski L, Koch C, Philippakis A, Cassa CA, Ellinor PT, Kathiresan S, Ng K, Lebo M, Khera AV. Association of Rare Pathogenic DNA Variants for Familial Hypercholesterolemia, Hereditary Breast and Ovarian Cancer Syndrome, and Lynch Syndrome With Disease Risk in Adults According to Family History. JAMA Netw Open 2020;3:e203959. [PMID: 32347951 DOI: 10.1001/jamanetworkopen.2020.3959] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
124 Jennings GL, Audehm R, Bishop W, Chow CK, Liaw ST, Liew D, Linton SM. National Heart Foundation of Australia: position statement on coronary artery calcium scoring for the primary prevention of cardiovascular disease in Australia. Med J Aust 2021;214:434-9. [PMID: 33960402 DOI: 10.5694/mja2.51039] [Reference Citation Analysis]
125 Zhou Y, Zhang S, Ji W, Gan X, Hua L, Hou C, Chen J, Wang Y, He S, Zhou H, Jia E. LncRNA Landscape of Coronary Atherosclerosis Reveals Differentially Expressed LncRNAs in Proliferation and Migration of Coronary Artery Smooth Muscle Cells. Front Cell Dev Biol 2021;9:656636. [PMID: 34084771 DOI: 10.3389/fcell.2021.656636] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 Sheikhy A, Fallahzadeh A, Sadeghian S, Forouzannia K, Bagheri J, Salehi-Omran A, Tajdini M, Jalali A, Pashang M, Hosseini K. Mid-term outcomes of off-pump versus on-pump coronary artery bypass graft surgery; statistical challenges in comparison. BMC Cardiovasc Disord 2021;21:412. [PMID: 34454415 DOI: 10.1186/s12872-021-02213-0] [Reference Citation Analysis]
127 Sachdev HS, Porwal A, Sarna A, Acharya R, Ramesh S, Kapil U, Kurpad AV. Intraindividual double-burden of anthropometric undernutrition and "metabolic obesity" in Indian children: a paradox that needs action. Eur J Clin Nutr 2021;75:1205-17. [PMID: 33893450 DOI: 10.1038/s41430-021-00916-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
128 Takeshita Y, Terada J, Fujita R, Hirasawa Y, Kinoshita T, Isaka Y, Kinouchi T, Tajima H, Tada Y, Kiryu S, Tsushima K. Coronary artery calcium score may be a novel predictor of COVID-19 prognosis: a retrospective study. BMJ Open Respir Res 2021;8:e000923. [PMID: 34272254 DOI: 10.1136/bmjresp-2021-000923] [Reference Citation Analysis]
129 Hejjaji V, Gosch K, Jones PG, Breeding T, Spertus JA, Arnold SV. Comanagement of Risk Factors in Patients With Coronary Artery Disease: Insights From the APPEAR Study. J Am Heart Assoc 2020;9:e015157. [PMID: 32441197 DOI: 10.1161/JAHA.119.015157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
130 Coleman KJ, Fischer H, Arterburn DE, Barthold D, Barton LJ, Basu A, Courcoulas A, Crawford CL, Fedorka P, Kim B, Mun E, Murali S, Reynolds K, Suh K, Wei R, Yoon TK, Zane R. Effectiveness of Gastric Bypass Versus Gastric Sleeve for Cardiovascular Disease: Protocol and Baseline Results for a Comparative Effectiveness Study. JMIR Res Protoc 2020;9:e14936. [PMID: 32249757 DOI: 10.2196/14936] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
131 Kang SH, Lee HW, Yoo JJ, Cho Y, Kim SU, Lee TH, Jang BK, Kim SG, Ahn SB, Kim H, Jun DW, Choi JI, Song DS, Kim W, Jeong SW, Kim MY, Koh H, Jeong S, Lee JW, Cho YK; Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease. Clin Mol Hepatol 2021;27:363-401. [PMID: 34154309 DOI: 10.3350/cmh.2021.0178] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
132 Lee J, Egolum U, Parihar H, Cooley M, Ling H. Effect of Ezetimibe Added to High-Intensity Statin Therapy on Low-Density Lipoprotein Cholesterol Levels: A Meta-Analysis. Cardiol Res 2021;12:98-108. [PMID: 33738013 DOI: 10.14740/cr1224] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
133 Zeng YY, Zhang M, Ko S, Chen F. An Update on Cardiovascular Risk Factors After Kawasaki Disease. Front Cardiovasc Med 2021;8:671198. [PMID: 33937365 DOI: 10.3389/fcvm.2021.671198] [Reference Citation Analysis]
134 Karvaly GB, Karádi I, Vincze I, Neely MN, Trojnár E, Prohászka Z, Imreh É, Vásárhelyi B, Zsáry A. A pharmacokinetics-based approach to the monitoring of patient adherence to atorvastatin therapy. Pharmacol Res Perspect 2021;9:e00856. [PMID: 34478238 DOI: 10.1002/prp2.856] [Reference Citation Analysis]
135 Kexin W, Yaodong D, Wen G, Rui W, Jiaxin Y, Xiaoli L, Hua S, Hailong G. Association of Increased Remnant Cholesterol and the Risk of Coronary Artery Disease: A Retrospective Study. Front Cardiovasc Med 2021;8:740596. [PMID: 34778402 DOI: 10.3389/fcvm.2021.740596] [Reference Citation Analysis]
136 Willeit P, Yeang C, Moriarty PM, Tschiderer L, Varvel SA, McConnell JP, Tsimikas S. Low-Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events. J Am Heart Assoc 2020;9:e016318. [PMID: 33222611 DOI: 10.1161/JAHA.119.016318] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
137 Hassan S, Oladele C, Galusha D, Adams OP, Maharaj RG, Nazario CM, Nunez M, Nunez-Smith M; ECHORN Writing Group. Anthropometric measures of obesity and associated cardiovascular disease risk in the Eastern Caribbean Health Outcomes Research Network (ECHORN) Cohort Study. BMC Public Health 2021;21:399. [PMID: 33632164 DOI: 10.1186/s12889-021-10399-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
138 Hodis JD, Gottesman RF, Windham BG, Knopman DS, Lutsey PL, Walker KA, Alonso A. Association of Hypertension According to New American College of Cardiology/American Heart Association Blood Pressure Guidelines With Incident Dementia in the ARIC Study Cohort. J Am Heart Assoc 2020;9:e017546. [PMID: 33170065 DOI: 10.1161/JAHA.120.017546] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
139 Hyun MH, Lee Y, Choi BG, Na JO, Choi CU, Kim JW, Kim EJ, Rha SW, Park CG, Lee E, Seo HS. Roles of Achieved Levels of Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein on Cardiovascular Outcome in Statin Therapy. Cardiovasc Ther 2019;2019:3824823. [PMID: 31885691 DOI: 10.1155/2019/3824823] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
140 Schwartz GG, Gabriel Steg P, Bhatt DL, Bittner VA, Diaz R, Goodman SG, Jukema JW, Kim YU, Li QH, Manvelian G, Pordy R, Sourdille T, White HD, Szarek M; ODYSSEY OUTCOMES Committees and Investigators. Clinical Efficacy and Safety of Alirocumab After Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial. Circulation 2021;143:1109-22. [PMID: 33438437 DOI: 10.1161/CIRCULATIONAHA.120.049447] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
141 Lee K, Jung JH, Lee M, Kim DW, Park MW, Choi IJ, Lee JH, Lee JH, Lee SR, Lee PH, Lee SW, Yoo KD, Yun KH, Lee HJ, Her SH. Clinical Outcome of Rotational Atherectomy in Calcified Lesions in Korea-ROCK Registry. Medicina (Kaunas) 2021;57:694. [PMID: 34356975 DOI: 10.3390/medicina57070694] [Reference Citation Analysis]
142 Roberts R, Fair J. A Less than Provocative Approach for the Primary Prevention of CAD. J Cardiovasc Transl Res 2021. [PMID: 34128181 DOI: 10.1007/s12265-021-10144-6] [Reference Citation Analysis]
143 Rodriguez A. High HDL-Cholesterol Paradox: SCARB1-LAG3-HDL Axis. Curr Atheroscler Rep 2021;23:5. [PMID: 33398433 DOI: 10.1007/s11883-020-00902-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
144 Flint AJ, Meyers BS, Rothschild AJ, Whyte EM, Alexopoulos GS, Rudorfer MV, Marino P, Banerjee S, Pollari CD, Wu Y, Voineskos AN, Mulsant BH; STOP-PD II Study Group. Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission: The STOP-PD II Randomized Clinical Trial. JAMA 2019;322:622-31. [PMID: 31429896 DOI: 10.1001/jama.2019.10517] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
145 Blume CA, Brust-Renck PG, Rocha MK, Leivas G, Neyeloff JL, Anzanello MJ, Fogliatto FS, Bahia LR, Telo GH, Schaan BD. Development and Validation of a Predictive Model of Success in Bariatric Surgery. Obes Surg 2021;31:1030-7. [PMID: 33190175 DOI: 10.1007/s11695-020-05103-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
146 Casey DE Jr, Thomas RJ, Bhalla V, Commodore-Mensah Y, Heidenreich PA, Kolte D, Muntner P, Smith SC Jr, Spertus JA, Windle JR, Wozniak GD, Ziaeian B. 2019 AHA/ACC Clinical Performance and Quality Measures for Adults With High Blood Pressure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. Circ Cardiovasc Qual Outcomes 2019;12:e000057. [PMID: 31714813 DOI: 10.1161/HCQ.0000000000000057] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
147 Kaiser H, Wang X, Kvist-Hansen A, Krakauer M, Gørtz PM, McCauley BD, Skov L, Becker C, Hansen PR. Biomarkers of subclinical atherosclerosis in patients with psoriasis. Sci Rep 2021;11:21438. [PMID: 34728734 DOI: 10.1038/s41598-021-00999-9] [Reference Citation Analysis]
148 Wong ND, Amsterdam EA, Ballantyne C, Khera A, Nasir K, Toth PP; American Society for Preventive Cardiology. Spotlight from the American Society for Preventive Cardiology on Key Features of the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guidelines on the Management of Blood Cholesterol. Am J Cardiovasc Drugs 2020;20:1-9. [PMID: 31286451 DOI: 10.1007/s40256-019-00358-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
149 Feinstein MJ, Hsue PY, Benjamin LA, Bloomfield GS, Currier JS, Freiberg MS, Grinspoon SK, Levin J, Longenecker CT, Post WS. Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association. Circulation 2019;140:e98-e124. [PMID: 31154814 DOI: 10.1161/CIR.0000000000000695] [Cited by in Crossref: 123] [Cited by in F6Publishing: 66] [Article Influence: 41.0] [Reference Citation Analysis]
150 Izumida T, Nakamura Y, Hino Y, Ishikawa S. Combined Effect of Small Dense Low-Density Lipoprotein Cholesterol (sdLDL-C) and Remnant-Like Particle Cholesterol (RLP-C) on Low-Grade Inflammation. J Atheroscler Thromb 2020;27:319-30. [PMID: 31462603 DOI: 10.5551/jat.49528] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
151 Ng K, Kartoun U, Stavropoulos H, Zambrano JA, Tang PC. Personalized treatment options for chronic diseases using precision cohort analytics. Sci Rep 2021;11:1139. [PMID: 33441956 DOI: 10.1038/s41598-021-80967-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
152 Dias AM, Cordeiro G, Estevinho MM, Veiga R, Figueira L, Reina-Couto M, Magro F; the Clinical Pharmacology Unit, São João Hospital University Centre. Gut bacterial microbiome composition and statin intake-A systematic review. Pharmacol Res Perspect 2020;8:e00601. [PMID: 32476298 DOI: 10.1002/prp2.601] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
153 Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC, Sperling L, Virani SS, Yeboah J. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139:e1082-e1143. [PMID: 30586774 DOI: 10.1161/cir.0000000000000625] [Cited by in Crossref: 250] [Cited by in F6Publishing: 310] [Article Influence: 62.5] [Reference Citation Analysis]
154 German CA, Shapiro MD. Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science. Eur Cardiol 2020;15:e56. [PMID: 32742310 DOI: 10.15420/ecr.2019.18] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
155 Liu L, Li H, Iyer H, Liu AJ, Zeng Y, Ji JS. Apolipoprotein E Induced Cognitive Dysfunction: Mediation Analysis of Lipids and Glucose Biomarkers in an Elderly Cohort Study. Front Aging Neurosci 2021;13:727289. [PMID: 34483892 DOI: 10.3389/fnagi.2021.727289] [Reference Citation Analysis]
156 Groth NA, Stone NJ, Benziger CP. Cardiology clinic visit increases likelihood of evidence-based cholesterol prescribing in severe hypercholesterolemia. Clin Cardiol 2021;44:186-92. [PMID: 33355940 DOI: 10.1002/clc.23521] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
157 Forman DE, de Lemos JA, Shaw LJ, Reuben DB, Lyubarova R, Peterson ED, Spertus JA, Zieman S, Salive ME, Rich MW; Geriatric Cardiology Section Leadership Council. Cardiovascular Biomarkers and Imaging in Older Adults: JACC Council Perspectives. J Am Coll Cardiol 2020;76:1577-94. [PMID: 32972536 DOI: 10.1016/j.jacc.2020.07.055] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
158 Zhang Y, Pletcher MJ, Vittinghoff E, Clemons AM, Jacobs DR Jr, Allen NB, Alonso A, Bellows BK, Oelsner EC, Zeki Al Hazzouri A, Kazi DS, de Ferranti SD, Moran AE. Association Between Cumulative Low-Density Lipoprotein Cholesterol Exposure During Young Adulthood and Middle Age and Risk of Cardiovascular Events. JAMA Cardiol 2021. [PMID: 34550307 DOI: 10.1001/jamacardio.2021.3508] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
159 Rodriguez F, Ngo S, Baird G, Balla S, Miles R, Garg M. Readability of Online Patient Educational Materials for Coronary Artery Calcium Scans and Implications for Health Disparities. J Am Heart Assoc 2020;9:e017372. [PMID: 32865121 DOI: 10.1161/JAHA.120.017372] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
160 Khan SU, Khan MU, Riaz H, Raggi P, Valavoor S, Khan MZ, Kołodziejczak M, Khan MS, Krupica T, Alkhouli M, Navarese EP. Meta-analysis of the Relation of Body Mass Index to Cardiovascular Outcomes in Patients Receiving Intensive Low-Density Lipoprotein Cholesterol Lowering Therapy. Am J Cardiol 2020;125:727-34. [PMID: 31898964 DOI: 10.1016/j.amjcard.2019.12.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
161 Luo D, Luo Y, Zou Y, Xu Y, Fu B, Yang D, Yang J, Xu C, Ling S, Li S, Qi A. Non-high-density lipoprotein cholesterol may predict the cardio-cerebrovascular risk in patients on maintenance hemodialysis. Lipids Health Dis 2021;20:159. [PMID: 34774042 DOI: 10.1186/s12944-021-01546-1] [Reference Citation Analysis]
162 Briers PJ, Langlois MR. Concordance of apolipoprotein B concentration with the Friedewald, Martin-Hopkins, and Sampson formulas for calculating LDL cholesterol. Biochem Med (Zagreb) 2022;32:010704. [PMID: 34955672 DOI: 10.11613/BM.2022.010704] [Reference Citation Analysis]
163 Jin JL, Zhang HW, Cao YX, Liu HH, Hua Q, Li YF, Zhang Y, Wu NQ, Zhu CG, Xu RX, Gao Y, Li XL, Cui CJ, Liu G, Sun J, Dong Q, Guo YL, Li JJ. Association of small dense low-density lipoprotein with cardiovascular outcome in patients with coronary artery disease and diabetes: a prospective, observational cohort study. Cardiovasc Diabetol 2020;19:45. [PMID: 32245386 DOI: 10.1186/s12933-020-01015-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
164 Schneider EE, Sarkar S, Margolick JB, Martin SS, Post WS, Brown TT. Short Communication: Comparison of Calculated Low-Density Lipoprotein Cholesterol (LDL-C) Values in HIV-Infected and HIV-Uninfected Men Using the Traditional Friedewald and the Novel Martin-Hopkins LDL-C Equations. AIDS Res Hum Retroviruses 2020;36:176-9. [PMID: 31813226 DOI: 10.1089/AID.2019.0220] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
165 Baker LH, Boonstra PS, Reinke DK, Antalis EJP, Zebrack BJ, Weinberg RL. Burden of chronic diseases among sarcoma survivors treated with anthracycline chemotherapy: results from an observational study. J Cancer Metastasis Treat 2020;6:24. [PMID: 34651082 DOI: 10.20517/2394-4722.2020.36] [Reference Citation Analysis]
166 Yoshida H, Ito K, Manita D, Sato R, Hiraishi C, Matsui S, Hirowatari Y. Clinical Significance of Intermediate-Density Lipoprotein Cholesterol Determination as a Predictor for Coronary Heart Disease Risk in Middle-Aged Men. Front Cardiovasc Med 2021;8:756057. [PMID: 34881308 DOI: 10.3389/fcvm.2021.756057] [Reference Citation Analysis]
167 Yiu JHC, Chan KS, Cheung J, Li J, Liu Y, Wang Y, Fung WWL, Cai J, Cheung SWM, Dorweiler B, Wan EYF, Tso P, Xu A, Woo CW. Gut Microbiota-Associated Activation of TLR5 Induces Apolipoprotein A1 Production in the Liver. Circ Res 2020;127:1236-52. [PMID: 32820707 DOI: 10.1161/CIRCRESAHA.120.317362] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
168 Nayor M, Murthy VL, Shah RV. For Non-HDL Cholesterol, "Lower Is Better" but "Lower for Longer" May Be Best. Circ Res 2020;126:836-8. [PMID: 32213138 DOI: 10.1161/CIRCRESAHA.120.316697] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
169 Shah LM, Wand A, Ying W, Hays AG, Blumenthal RS, Barouch LA, Zakaria S, Sharma G. Prevention Starts in the Womb: Opportunities for Addressing Cardiovascular Risk Factors During Pregnancy and Beyond. Methodist Debakey Cardiovasc J 2021;17:48-59. [PMID: 34824681 DOI: 10.14797/mdcvj.696] [Reference Citation Analysis]
170 Rämö JT, Ripatti P, Tabassum R, Söderlund S, Matikainen N, Gerl MJ, Klose C, Surma MA, Stitziel NO, Havulinna AS, Pirinen M, Salomaa V, Freimer NB, Jauhiainen M, Palotie A, Taskinen MR, Simons K, Ripatti S. Coronary Artery Disease Risk and Lipidomic Profiles Are Similar in Hyperlipidemias With Family History and Population-Ascertained Hyperlipidemias. J Am Heart Assoc 2019;8:e012415. [PMID: 31256696 DOI: 10.1161/JAHA.119.012415] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
171 Ikezaki H, Lim E, Cupples LA, Liu CT, Asztalos BF, Schaefer EJ. Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study. J Am Heart Assoc 2021;10:e019140. [PMID: 33586462 DOI: 10.1161/JAHA.120.019140] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
172 Patel H, Aggarwal NT, Rao A, Bryant E, Sanghani RM, Byrnes M, Kalra D, Dairaghi L, Braun L, Gabriel S, Volgman AS. Microvascular Disease and Small-Vessel Disease: The Nexus of Multiple Diseases of Women. J Womens Health (Larchmt) 2020;29:770-9. [PMID: 32074468 DOI: 10.1089/jwh.2019.7826] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
173 Huang YC, Lee JD, Weng HH, Lin LC, Tsai YH, Yang JT. Statin and dual antiplatelet therapy for the prevention of early neurological deterioration and recurrent stroke in branch atheromatous disease: a protocol for a prospective single-arm study using a historical control for comparison. BMJ Open 2021;11:e054381. [PMID: 34836908 DOI: 10.1136/bmjopen-2021-054381] [Reference Citation Analysis]
174 Jia X, Al Rifai M, Gluckman TJ, Birnbaum Y, Virani SS. Highlights from Selected Cardiovascular Disease Prevention Studies Presented at the 2019 European Society of Cardiology Congress. Curr Atheroscler Rep 2019;21:46. [PMID: 31741082 DOI: 10.1007/s11883-019-0813-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
175 Cohen H, Stefanutti C; and The Mighty Medic Satellite Research Group for Pediatric Dyslipidemia. Current Approach to the Diagnosis and Treatment of Heterozygote and Homozygous FH Children and Adolescents. Curr Atheroscler Rep 2021;23:30. [PMID: 33963467 DOI: 10.1007/s11883-021-00926-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
176 Tran DT, Palfrey D, Welsh R. The Healthcare Cost Burden in Adults with High Risk for Cardiovascular Disease. Pharmacoecon Open 2021;5:425-35. [PMID: 33484443 DOI: 10.1007/s41669-021-00257-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
177 Metser G, Bradley C, Moise N, Liyanage-Don N, Kronish I, Ye S. Gaps and Disparities in Primary Prevention Statin Prescription During Outpatient Care. Am J Cardiol 2021;161:36-41. [PMID: 34794616 DOI: 10.1016/j.amjcard.2021.08.070] [Reference Citation Analysis]
178 Liu WT, Lin C, Tsai MC, Cheng CC, Chen SJ, Liou JT, Lin WS, Cheng SM, Lin CS, Tsao TP. Effects of Pitavastatin, Atorvastatin, and Rosuvastatin on the Risk of New-Onset Diabetes Mellitus: A Single-Center Cohort Study. Biomedicines 2020;8:E499. [PMID: 33202854 DOI: 10.3390/biomedicines8110499] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
179 Groth SW, Fernandez ID, Block RC, Thurston SW, Wong E, Brunner J, Mayo N, Kapula N, Yu Y, Meng Y, Yeh KL, Kinkade CW, Thornburg LL, O'Connor TG, Barrett ES. Biological changes in the pregnancy-postpartum period and subsequent cardiometabolic risk-UPSIDE MOMS: A research protocol. Res Nurs Health 2021;44:608-19. [PMID: 33993510 DOI: 10.1002/nur.22141] [Reference Citation Analysis]
180 Eun MY, Jung JM, Choi KH, Seo WK. Statin Effects in Atrial Fibrillation-Related Stroke: A Systematic Review and Meta-Analysis. Front Neurol 2020;11:589684. [PMID: 33162931 DOI: 10.3389/fneur.2020.589684] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
181 Zeitler EP, Gasperetti A, Dodge SE, Cooper LB, Kaplan AV. Funding of Studies Supporting IA Guideline Recommendations in Cardiovascular Medicine-A Systematic Review. J Am Heart Assoc 2021;10:e019513. [PMID: 33960212 DOI: 10.1161/JAHA.120.019513] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
182 Mcnavish DE, German CA, Shapiro MD. Should a Statin be Given to All Hypertensive Patients? Curr Hypertens Rep. [DOI: 10.1007/s11906-022-01167-8] [Reference Citation Analysis]
183 Jeon-Slaughter H, Chen X, Tsai S, Ramanan B, Ebrahimi R. Developing an Internally Validated Veterans Affairs Women Cardiovascular Disease Risk Score Using Veterans Affairs National Electronic Health Records. J Am Heart Assoc 2021;10:e019217. [PMID: 33619994 DOI: 10.1161/JAHA.120.019217] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
184 Pouwer MG, Pieterman EJ, Worms N, Keijzer N, Jukema JW, Gromada J, Gusarova V, Princen HMG. Alirocumab, evinacumab, and atorvastatin triple therapy regresses plaque lesions and improves lesion composition in mice. J Lipid Res 2020;61:365-75. [PMID: 31843957 DOI: 10.1194/jlr.RA119000419] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
185 Lee WC, Fang CY, Chen CJ, Yang CH, Wu CJ, Fang HY. The Clinical Outcomes Based on the Achievement of Low-Density Lipoprotein Cholesterol Targets after ST Elevation Myocardial Infarction. J Clin Med 2019;9:E79. [PMID: 31905621 DOI: 10.3390/jcm9010079] [Reference Citation Analysis]
186 Jialal I, Singh G. Management of diabetic dyslipidemia: An update. World J Diabetes 2019; 10(5): 280-290 [PMID: 31139315 DOI: 10.4239/wjd.v10.i5.280] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
187 Pearson K, Ngo S, Ekpo E, Sarraju A, Baird G, Knowles J, Rodriguez F. Online Patient Education Materials Related to Lipoprotein(a): Readability Assessment. J Med Internet Res 2022;24:e31284. [PMID: 35014955 DOI: 10.2196/31284] [Reference Citation Analysis]
188 Benaiges D, Goday A, Flores-Le Roux JA, Fitó M, Pozo O, Rodríguez-Morató J, Serra C, Pera M, Llauradó G, Climent E, Castañer O, Ramon JM, Pedro-Botet J. Bariatric surgery and LDL cholesterol (BASALTO) trial study protocol: randomised controlled study evaluating the effect of gastric bypass versus sleeve gastrectomy on high LDL cholesterol. BMJ Open 2020;10:e037712. [PMID: 32912989 DOI: 10.1136/bmjopen-2020-037712] [Reference Citation Analysis]
189 Carrillo-Larco RM, Albitres-Flores L, Barengo NC, Bernabe-Ortiz A. The association between serum lipids and risk of premature mortality in Latin America: a systematic review of population-based prospective cohort studies. PeerJ 2019;7:e7856. [PMID: 31592360 DOI: 10.7717/peerj.7856] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
190 Chun S, Imakaev M, Hui D, Patsopoulos NA, Neale BM, Kathiresan S, Stitziel NO, Sunyaev SR. Non-parametric Polygenic Risk Prediction via Partitioned GWAS Summary Statistics. Am J Hum Genet 2020;107:46-59. [PMID: 32470373 DOI: 10.1016/j.ajhg.2020.05.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
191 Izar MCO, Giraldez VZR, Bertolami A, Santos Filho RDD, Lottenberg AM, Assad MHV, Saraiva JFK, Chacra APM, Martinez TLR, Bahia LR, Fonseca FAH, Faludi AA, Sposito AC, Chagas ACP, Jannes CE, Amaral CK, Araújo DB, Cintra DE, Coutinho EDR, Cesena F, Xavier HT, Mota ICP, Giuliano ICB, Faria Neto JR, Kato JT, Bertolami MC, Miname MH, Castelo MHCG, Lavrador MSF, Machado RM, Souza PG, Alves RJ, Machado VA, Salgado Filho W. Update of the Brazilian Guideline for Familial Hypercholesterolemia - 2021. Arq Bras Cardiol 2021;117:782-844. [PMID: 34709306 DOI: 10.36660/abc.20210788] [Reference Citation Analysis]
192 Will M, Mascherbauer J. Patient engagement in cardiology-nice or necessary? Wien Klin Wochenschr 2021;133:747-9. [PMID: 34406480 DOI: 10.1007/s00508-021-01929-5] [Reference Citation Analysis]
193 Jung HW, Hong SP, Kim KS. Comparison of apolipoprotein B/A1 ratio, TC/HDL-C, and lipoprotein (a) for predicting outcomes after PCI. PLoS One 2021;16:e0254677. [PMID: 34255802 DOI: 10.1371/journal.pone.0254677] [Reference Citation Analysis]
194 Guo LL, Zhu LY, Xu J, Xie YY, Xiang QY, Jiang ZY, Tan YR, Liu L. Determination of the Optimal Cutoff Value of Triglyceride That Corresponds to Fasting Levels in Chinese Subjects With Marked Hypertriglyceridemia. Front Cardiovasc Med 2021;8:736059. [PMID: 34631833 DOI: 10.3389/fcvm.2021.736059] [Reference Citation Analysis]
195 Hilvo M, Vasile VC, Donato LJ, Hurme R, Laaksonen R. Ceramides and Ceramide Scores: Clinical Applications for Cardiometabolic Risk Stratification. Front Endocrinol (Lausanne) 2020;11:570628. [PMID: 33133018 DOI: 10.3389/fendo.2020.570628] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
196 Kongmalai T, Chuanchaiyakul N, Sripatumtong C, Tansit T, Srinoulprasert Y, Klinsukon N, Thongtang N. The effect of temperature on the stability of PCSK-9 monoclonal antibody: an experimental study. Lipids Health Dis 2021;20:21. [PMID: 33632254 DOI: 10.1186/s12944-021-01447-3] [Reference Citation Analysis]
197 Frost L, Gerds T, Vinter N. Perfusion imaging combined with coronary calcium scoring. A step further towards individualized medicine? Int J Cardiol Heart Vasc 2021;35:100845. [PMID: 34381868 DOI: 10.1016/j.ijcha.2021.100845] [Reference Citation Analysis]
198 Penson PE, Banach M. Nutraceuticals for the Control of Dyslipidaemias in Clinical Practice. Nutrients 2021;13:2957. [PMID: 34578834 DOI: 10.3390/nu13092957] [Reference Citation Analysis]
199 Kinnear FJ, Hamilton-Shield JP, Stensel DJ, Bayly G, Searle A, Thackray AE, Lithander FE. Nutrition and physical activity intervention for families with familial hypercholesterolaemia: protocol for a pilot randomised controlled feasibility study. Pilot Feasibility Stud 2020;6:42. [PMID: 32266080 DOI: 10.1186/s40814-020-00584-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
200 Phoon IKY, Koh YLE, Guo X, Usha S, Tan NC. Compatibility between an overnight fasting and random cholesterol tests in Asians. Sci Rep 2021;11:6478. [PMID: 33742059 DOI: 10.1038/s41598-021-85914-y] [Reference Citation Analysis]
201 Lu MT, Ivanov A, Mayrhofer T, Hosny A, Aerts HJWL, Hoffmann U. Deep Learning to Assess Long-term Mortality From Chest Radiographs. JAMA Netw Open 2019;2:e197416. [PMID: 31322692 DOI: 10.1001/jamanetworkopen.2019.7416] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 12.0] [Reference Citation Analysis]
202 Yoon YE, Yun B, Kim KM, Suh JW. Breast Arterial Calcification: A Potential Biomarker for Atherosclerotic Cardiovascular Disease Risk? Curr Atheroscler Rep 2021;23:21. [PMID: 33772359 DOI: 10.1007/s11883-021-00924-5] [Reference Citation Analysis]
203 Piccinni C, Antonazzo IC, Maggioni AP, Pedrini A, Calabria S, Ronconi G, Dondi L, Martini N, Roberto G, Sampietro T, Sbrana F, Pino BD, Bigazzi F, Surdo GL, Volpi E, Biagini S, Gini R. PCSK9 Inhibitors’ New Users: Analysis of Prescription Patterns and Patients’ Characteristics from an Italian Real-world Study. Clin Drug Investig 2020;40:173-81. [DOI: 10.1007/s40261-019-00877-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
204 Amengual J, Coronel J, Marques C, Aradillas-García C, Morales JMV, Andrade FCD, Erdman JW, Teran-Garcia M. β-Carotene Oxygenase 1 Activity Modulates Circulating Cholesterol Concentrations in Mice and Humans. J Nutr 2020;150:2023-30. [PMID: 32433733 DOI: 10.1093/jn/nxaa143] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
205 Kirkpatrick CF, Maki KC. Dietary Influences on Atherosclerotic Cardiovascular Disease Risk. Curr Atheroscler Rep 2021;23:62. [PMID: 34405289 DOI: 10.1007/s11883-021-00954-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
206 Shi H, Ossip DJ, Mayo NL, Lopez DA, Block RC, Post WS, Bertoni AG, Ding J, Chen S, Yan C, Xie Z, Hoeschele I, Liu Y, Li D. Role of DNA methylation on the association between physical activity and cardiovascular diseases: results from the longitudinal multi-ethnic study of atherosclerosis (MESA) cohort. BMC Genomics 2021;22:790. [PMID: 34732130 DOI: 10.1186/s12864-021-08108-w] [Reference Citation Analysis]
207 Salsoso R, Dalcoquio TF, Furtado RHM, Franci A, Barbosa CJDG, Genestreti PRR, Strunz CMC, Lima V, Baracioli LM, Giugliano RP, Goodman SG, Gurbel PA, Maranhão RC, Nicolau JC. Relation of High Lipoprotein (a) Concentrations to Platelet Reactivity in Individuals with and Without Coronary Artery Disease. Adv Ther 2020;37:4568-84. [PMID: 32889667 DOI: 10.1007/s12325-020-01483-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
208 Fath F, Bengeser A, Barresi M, Binner P, Schwab S, Ray KK, Krämer BK, Fraass U, März W. FH ALERT: efficacy of a novel approach to identify patients with familial hypercholesterolemia. Sci Rep 2021;11:20421. [PMID: 34650182 DOI: 10.1038/s41598-021-99961-y] [Reference Citation Analysis]
209 Jeon YJ, Pyo J, Park YK, Ock M. Health behaviors in major chronic diseases patients: trends and regional variations analysis, 2008-2017, Korea. BMC Public Health 2020;20:1813. [PMID: 33246439 DOI: 10.1186/s12889-020-09940-7] [Reference Citation Analysis]
210 D'Assante R, De Luca M, Ferraro S, Ferraro A, Ruvolo A, Natale F, Sotgiu P, Petitto M, Rizzo R, De Maria U, Liguori L, Gentile G, Ragucci P, Donadio V, Valente V, Cittadini A. Beneficial Metabolic Effect of a Nutraceuticals Combination (Monacolin K, Yeasted Red Rice, Polyphenolic Extract of Annurca Apple and Berberine) on Acquired Hypercholesterolemia: A Prospective Analysis. Metabolites 2021;11:223. [PMID: 33917635 DOI: 10.3390/metabo11040223] [Reference Citation Analysis]
211 Shaya FT, Sing K, Milam R, Husain F, Del Aguila MA, Patel MY. Lipid-Lowering Efficacy of Ezetimibe in Patients with Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analyses. Am J Cardiovasc Drugs 2020;20:239-48. [PMID: 31724105 DOI: 10.1007/s40256-019-00379-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
212 Sun CJ, McCudden C, Brisson D, Shaw J, Gaudet D, Ooi TC. Calculated Non-HDL Cholesterol Includes Cholesterol in Larger Triglyceride-Rich Lipoproteins in Hypertriglyceridemia. J Endocr Soc 2020;4:bvz010. [PMID: 32010872 DOI: 10.1210/jendso/bvz010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
213 Pearson K, Rodriguez F. Lipoprotein(a) and Cardiovascular Disease Prevention across Diverse Populations. Cardiol Ther 2020;9:275-92. [PMID: 32451810 DOI: 10.1007/s40119-020-00177-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
214 Guadamuz JS, Durazo-Arvizu RA, Daviglus ML, Calip GS, Nutescu EA, Qato DM. Citizenship Status and the Prevalence, Treatment, and Control of Cardiovascular Disease Risk Factors Among Adults in the United States, 2011-2016. Circ Cardiovasc Qual Outcomes 2020;13:e006215. [PMID: 32151148 DOI: 10.1161/CIRCOUTCOMES.119.006215] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
215 Jia X, Lee MT, Ramsey DJ, Al Rifai M, Mahtta D, Krittanawong C, Akeroyd JM, Matheny ME, Gobbel G, Stone NJ, Ballantyne CM, Petersen LA, Virani SS. Facility-Level Variation in Reported Statin-Associated Side Effects Among Patients with Atherosclerotic Cardiovascular Disease-Perspective from the Veterans Affair Healthcare System. Cardiovasc Drugs Ther 2021. [PMID: 33523335 DOI: 10.1007/s10557-021-07148-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
216 Zhai Q, Wen J, Wang M, Zuo Y, Su X, Zhang Y, Gaisano H, He Y. Glomerular Hyperfiltration Interacts With Abnormal Metabolism to Enhance Arterial Stiffness in Middle-Aged and Elderly People. Front Med (Lausanne) 2021;8:732413. [PMID: 34746175 DOI: 10.3389/fmed.2021.732413] [Reference Citation Analysis]
217 Ganz P, Deo R, Dubin RF. Proteomics for personalized cardiovascular risk assessment: in pursuit of the Holy Grail. Eur Heart J 2020;41:4008-10. [PMID: 32901246 DOI: 10.1093/eurheartj/ehaa661] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
218 Badon SE, Gabriel KP, Karvonen-Gutierrez C, Sternfeld B, Gold EB, Waetjen LE, Lee C, Avalos LA, El Khoudary SR, Hedderson MM. Dual trajectories of physical activity and blood lipids in midlife women: The Study of Women's Health Across the Nation. Maturitas 2021;146:49-56. [PMID: 33722364 DOI: 10.1016/j.maturitas.2021.02.002] [Reference Citation Analysis]
219 Ye Y, Chen X, Han J, Jiang W, Natarajan P, Zhao H. Interactions Between Enhanced Polygenic Risk Scores and Lifestyle for Cardiovascular Disease, Diabetes, and Lipid Levels. Circ Genom Precis Med 2021;14:e003128. [PMID: 33433237 DOI: 10.1161/CIRCGEN.120.003128] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
220 Jones LK, Tilberry S, Gregor C, Yaeger LH, Hu Y, Sturm AC, Seaton TL, Waltz TJ, Rahm AK, Goldberg A, Brownson RC, Gidding SS, Williams MS, Gionfriddo MR. Implementation strategies to improve statin utilization in individuals with hypercholesterolemia: a systematic review and meta-analysis. Implement Sci 2021;16:40. [PMID: 33849601 DOI: 10.1186/s13012-021-01108-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
221 Nayor M, Brown KJ, Vasan RS. The Molecular Basis of Predicting Atherosclerotic Cardiovascular Disease Risk. Circ Res 2021;128:287-303. [PMID: 33476202 DOI: 10.1161/CIRCRESAHA.120.315890] [Reference Citation Analysis]
222 Johannesen CDL, Langsted A, Mortensen MB, Nordestgaard BG. Association between low density lipoprotein and all cause and cause specific mortality in Denmark: prospective cohort study. BMJ 2020;371:m4266. [PMID: 33293274 DOI: 10.1136/bmj.m4266] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
223 Min HK, Kim SH, Choi JH, Choi K, Kim HR, Lee SH. Impacts of statin and metformin on neuropathy in patients with type 2 diabetes mellitus: Korean Health Insurance data. World J Clin Cases 2021; 9(33): 10198-10207 [PMID: 34904090 DOI: 10.12998/wjcc.v9.i33.10198] [Reference Citation Analysis]
224 Yap J, Chew DP, Stone GW, Tan JWC. Pharmacotherapy in Stable Coronary Artery Disease: Historical Perspectives and New Insights from the ISCHEMIA Trial. Eur Cardiol 2021;16:e04. [PMID: 33737958 DOI: 10.15420/ecr.2020.48] [Reference Citation Analysis]
225 Castaldelli-Maia JM, Hofmann C, Chagas ACP, Liprandi AS, Alcocer A, Andrade LH, Wielgosz A. Major Cardiac-Psychiatric Drug-Drug Interactions: a Systematic Review of the Consistency of Drug Databases. Cardiovasc Drugs Ther 2021;35:441-54. [PMID: 32424652 DOI: 10.1007/s10557-020-06979-x] [Reference Citation Analysis]
226 Chidambaram V, Ruelas Castillo J, Kumar A, Wei J, Wang S, Majella MG, Gupte A, Wang JY, Karakousis PC. The association of atherosclerotic cardiovascular disease and statin use with inflammation and treatment outcomes in tuberculosis. Sci Rep 2021;11:15283. [PMID: 34315941 DOI: 10.1038/s41598-021-94590-x] [Reference Citation Analysis]
227 Cao YX, Zhang HW, Jin JL, Liu HH, Zhang Y, Gao Y, Guo YL, Wu NQ, Hua Q, Li YF, Li XL, Xu RX, Cui CJ, Liu G, Dong Q, Sun J, Zhu CG, Li JJ. The longitudinal association of remnant cholesterol with cardiovascular outcomes in patients with diabetes and pre-diabetes. Cardiovasc Diabetol 2020;19:104. [PMID: 32631321 DOI: 10.1186/s12933-020-01076-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
228 Baliyan V, Scholtz JE, Kordbacheh H, Hedgire S, Ghoshhajra BB. False-Negative Low Tube Voltage Coronary CT Angiography: High Intravascular Attenuation at Coronary CT Angiography Can Mask Calcified Plaques. Radiol Cardiothorac Imaging 2019;1:e190039. [PMID: 33778520 DOI: 10.1148/ryct.2019190039] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
229 Liu C, Guan T, Lai Y, Zhan J, Shen Y. Genetic predisposition and bioinformatics analysis of ATP-sensitive potassium channels polymorphisms with the risks of elevated apolipoprotein B serum levels and its related arteriosclerosis cardiovascular disease. Aging (Albany NY) 2021;13:8177-203. [PMID: 33686948 DOI: 10.18632/aging.202628] [Reference Citation Analysis]
230 Jones LK, McMinn M, Kann D, Lesko M, Sturm AC, Walters N, Chen N, Fry K, Brownson RC, Gidding SS, Williams MS, Rahm AK. Evaluation of a multidisciplinary lipid clinic to improve the care of individuals with severe lipid conditions: a RE-AIM framework analysis. Implement Sci Commun 2021;2:32. [PMID: 33741054 DOI: 10.1186/s43058-021-00135-8] [Reference Citation Analysis]
231 Oe M, Fujihara K, Harada-Yamada M, Osawa T, Kitazawa M, Matsubayashi Y, Sato T, Yaguchi Y, Iwanaga M, Seida H, Yamada T, Sone H. Impact of prior cerebrovascular disease and glucose status on incident cerebrovascular disease in Japanese. Cardiovasc Diabetol 2021;20:174. [PMID: 34479567 DOI: 10.1186/s12933-021-01367-7] [Reference Citation Analysis]
232 Honigberg MC, Zekavat SM, Niroula A, Griffin GK, Bick AG, Pirruccello JP, Nakao T, Whitsel EA, Farland LV, Laurie C, Kooperberg C, Manson JE, Gabriel S, Libby P, Reiner AP, Ebert BL, Natarajan P; NHLBI Trans-Omics for Precision Medicine Program. Premature Menopause, Clonal Hematopoiesis, and Coronary Artery Disease in Postmenopausal Women. Circulation 2021;143:410-23. [PMID: 33161765 DOI: 10.1161/CIRCULATIONAHA.120.051775] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
233 Huo S, Sun L, Zong G, Song B, Zheng H, Jin Q, Li H, Lin X. Genetic susceptibility, dietary cholesterol intake, and plasma cholesterol levels in a Chinese population. J Lipid Res 2020;61:1504-11. [PMID: 32817344 DOI: 10.1194/jlr.RA120001009] [Reference Citation Analysis]
234 Liu T, Yoon WS, Lee SR. Recent Updates of Lipoprotein(a) and Cardiovascular Disease. Chonnam Med J 2021;57:36-43. [PMID: 33537217 DOI: 10.4068/cmj.2021.57.1.36] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
235 Zhou H, Zhang S, Sun X, Yang D, Zhuang X, Guo Y, Hu X, Du Z, Zhang M, Liao X. Lipid management for coronary heart disease patients: an appraisal of updated international guidelines applying Appraisal of Guidelines for Research and Evaluation II-clinical practice guideline appraisal for lipid management in coronary heart disease. J Thorac Dis 2019;11:3534-46. [PMID: 31559060 DOI: 10.21037/jtd.2019.07.71] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
236 Sharma C, Platat C, Gariballa S, Muhairi SJA, Aidaros AA, Mannaerts GHH, Al Afari HS, Yasin J, Y Al-Dirbashi O, Alkaabi J. Metabolomic Profiling of Lipids and Fatty Acids: 3 Years Postoperative Laparoscopic Sleeve Gastrectomy. Biology (Basel) 2021;10:298. [PMID: 33916397 DOI: 10.3390/biology10040298] [Reference Citation Analysis]
237 Khedr D, Hafez M, Lumpuy-Castillo J, Emam S, Abdel-Massih A, Elmougy F, Elkaffas R, Mahillo-Fernández I, Lorenzo O, Musa N. Lipid Biomarkers as Predictors of Diastolic Dysfunction in Diabetes with Poor Glycemic Control. Int J Mol Sci 2020;21:E5079. [PMID: 32708413 DOI: 10.3390/ijms21145079] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
238 Lu JM, Wu MY, Yang ZM, Zhu Y, Li D, Yu ZB, Shen P, Tang ML, Jin MJ, Lin HB, Shui LM, Chen K, Wang JB. Low LDL-C levels are associated with risk of mortality in a Chinese cohort study. Endocrine 2021;73:563-72. [PMID: 33990892 DOI: 10.1007/s12020-021-02746-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
239 Gebhardt A, Fichtenbaum CJ. Current pharmacotherapy for the treatment of dyslipidemia associated with HIV infection. Expert Opin Pharmacother 2019;20:1719-29. [PMID: 31232617 DOI: 10.1080/14656566.2019.1636033] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
240 Fogacci F, Borghi C, Cicero AFG. Misinterpreting data in lipidology in the era of COVID-19. J Clin Lipidol 2020;14:543-4. [PMID: 32768364 DOI: 10.1016/j.jacl.2020.07.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
241 Alanbaei M, Abu-Farha M, Hebbar P, Melhem M, Chandy BS, Anoop E, Cherian P, Al-Khairi I, Alkayal F, Al-Mulla F, Abubaker J, Thanaraj TA. ANGPTL3 Variants Associate with Lower Levels of Irisin and C-Peptide in a Cohort of Arab Individuals. Genes (Basel) 2021;12:755. [PMID: 34067751 DOI: 10.3390/genes12050755] [Reference Citation Analysis]
242 Adams SM, Feroze H, Nguyen T, Eum S, Cornelio C, Harralson AF. Genome Wide Epistasis Study of On-Statin Cardiovascular Events with Iterative Feature Reduction and Selection. J Pers Med 2020;10:E212. [PMID: 33171725 DOI: 10.3390/jpm10040212] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
243 Tindall AM, Kris-Etherton PM, Petersen KS. Replacing Saturated Fats with Unsaturated Fats from Walnuts or Vegetable Oils Lowers Atherogenic Lipoprotein Classes Without Increasing Lipoprotein(a). J Nutr 2020;150:818-25. [PMID: 31909809 DOI: 10.1093/jn/nxz313] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
244 Agarwala A, Shapiro MD. Emerging Strategies for the Management of Atherogenic Dyslipidaemia. Eur Cardiol 2020;15:1-3. [PMID: 32180837 DOI: 10.15420/ecr.2019.16] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
245 Lee JW, Lim H, Kim JH, Kim HS. Reassessment of Inclusion Criteria in the 2013 the American College of Cardiology and the American Heart Association Cholesterol Guidelines for Cardiovascular Disease Prevention. J Clin Neurol 2021;17:86-95. [PMID: 33480203 DOI: 10.3988/jcn.2021.17.1.86] [Reference Citation Analysis]
246 Thongtang N, Tangkittikasem N, Samaithongcharoen K, Piyapromdee J, Srinonprasert V, Sriussadaporn S. Effect of Switching from Low-Dose Simvastatin to High-Dose Atorvastatin on Glucose Homeostasis and Cognitive Function in Type 2 Diabetes. Vasc Health Risk Manag 2020;16:367-77. [PMID: 33061398 DOI: 10.2147/VHRM.S270751] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
247 Blaha MJ, Whelton SP, Al Rifai M, Dardari Z, Shaw LJ, Al-Mallah MH, Matsushita K, Rozanski A, Rumberger JA, Berman DS, Budoff MJ, Miedema MD, Nasir K, Cainzos-Achirica M. Comparing Risk Scores in the Prediction of Coronary and Cardiovascular Deaths: Coronary Artery Calcium Consortium. JACC Cardiovasc Imaging 2021;14:411-21. [PMID: 31954640 DOI: 10.1016/j.jcmg.2019.12.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
248 Lowenstern A, Alexander KP, Hill CL, Alhanti B, Pellikka PA, Nanna MG, Mehta RH, Cooper LS, Bullock-Palmer RP, Hoffmann U, Douglas PS. Age-Related Differences in the Noninvasive Evaluation for Possible Coronary Artery Disease: Insights From the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) Trial. JAMA Cardiol 2020;5:193-201. [PMID: 31738382 DOI: 10.1001/jamacardio.2019.4973] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
249 Lan Y, Sun W, Chen Y, Miao J, Li G, Qiu X, Song X, Zhao X, Zhu Z, Fan Y, Zhu S. Nomogram Including Neutrophil-to-Lymphocyte Ratio for the Prediction of Stroke-Associated Infections. Front Neurol 2020;11:574280. [PMID: 33224089 DOI: 10.3389/fneur.2020.574280] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
250 Toth PP. Low-Density Lipoprotein Cholesterol Treatment Rates in High Risk Patients: More Disappointment Despite Ever More Refined Evidence-Based Guidelines. Am J Prev Cardiol 2021;6:100186. [PMID: 34327506 DOI: 10.1016/j.ajpc.2021.100186] [Reference Citation Analysis]
251 Sumayin Ngamdu K, Adewale OO, Mallawaarachchi I, Alozie OK, Dwivedi AK, Bhatt DL. Association Between the Framingham Risk Score and Carotid Artery Intima-Media Thickness in Patients With Human Immunodeficiency Virus. Am J Cardiol 2020;127:156-62. [PMID: 32466846 DOI: 10.1016/j.amjcard.2020.04.019] [Reference Citation Analysis]
252 Izumida T, Nakamura Y, Sato Y, Ishikawa S. Association among age, gender, menopausal status and small dense low-density lipoprotein cholesterol: a cross-sectional study. BMJ Open 2021;11:e041613. [PMID: 33542041 DOI: 10.1136/bmjopen-2020-041613] [Reference Citation Analysis]
253 Hadley TD, Agha AM, Ballantyne CM. How Do We Incorporate Polygenic Risk Scores in Cardiovascular Disease Risk Assessment and Management? Curr Atheroscler Rep 2021;23:28. [PMID: 33791884 DOI: 10.1007/s11883-021-00915-6] [Reference Citation Analysis]
254 Postolache TT, Medoff DR, Brown CH, Fang LJ, Upadhyaya SK, Lowry CA, Miller M, Kreyenbuhl JA. Lipophilic vs. hydrophilic statins and psychiatric hospitalizations and emergency room visits in US Veterans with schizophrenia and bipolar disorder. Pteridines 2021;32:48-69. [PMID: 34887622 DOI: 10.1515/pteridines-2020-0028] [Reference Citation Analysis]
255 Sullivan VK, Petersen KS, Kris-Etherton PM. Dried fruit consumption and cardiometabolic health: a randomised crossover trial. Br J Nutr 2020;124:912-21. [PMID: 32513313 DOI: 10.1017/S0007114520002007] [Reference Citation Analysis]
256 Ruscica M, Ferri N, Santos RD, Sirtori CR, Corsini A. Lipid Lowering Drugs: Present Status and Future Developments. Curr Atheroscler Rep 2021;23:17. [PMID: 33694108 DOI: 10.1007/s11883-021-00918-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
257 Wang SC, Kaur G, Schulman-Marcus J, Purga S, Mookherjee S, Miller C, Sidhu MS, Rosenson RS. Implementation of Cholesterol-Lowering Therapy to Reduce Cardiovascular Risk in Persons Living with HIV. Cardiovasc Drugs Ther 2020. [PMID: 32979175 DOI: 10.1007/s10557-020-07085-8] [Reference Citation Analysis]
258 Ajmal M, Singh A, Kubba S, Hershman M, Acharya T. Statin-Induced Triad of Autoimmune Myocarditis, Myositis, and Transaminitis. Case Rep Cardiol 2021;2021:6660362. [PMID: 33898067 DOI: 10.1155/2021/6660362] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
259 Lorenzatti AJ, Monsalvo ML, López JAG, Wang H, Rosenson RS. Effects of evolocumab in individuals with type 2 diabetes with and without atherogenic dyslipidemia: An analysis from BANTING and BERSON. Cardiovasc Diabetol 2021;20:94. [PMID: 33941192 DOI: 10.1186/s12933-021-01287-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
260 Giglio RV, Pantea Stoian A, Al-Rasadi K, Banach M, Patti AM, Ciaccio M, Rizvi AA, Rizzo M. Novel Therapeutical Approaches to Managing Atherosclerotic Risk. Int J Mol Sci 2021;22:4633. [PMID: 33924893 DOI: 10.3390/ijms22094633] [Reference Citation Analysis]
261 Melhem AL, Chourasia MK, Bigossi M, Maroteau C, Taylor A, Pola R, Dawed AY, Tornio A, Palmer CNA, Siddiqui MK. Common Statin Intolerance Variants in ABCB1 and LILRB5 Show Synergistic Effects on Statin Response: An Observational Study Using Electronic Health Records. Front Genet 2021;12:713181. [PMID: 34659336 DOI: 10.3389/fgene.2021.713181] [Reference Citation Analysis]
262 Lv F, Cai X, Hu D, Pan C, Zhang D, Xu J, Ji L. Characteristics of Newly Diagnosed Type 2 Diabetes in Chinese Older Adults: A National Prospective Cohort Study. J Diabetes Res 2019;2019:5631620. [PMID: 31828163 DOI: 10.1155/2019/5631620] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
263 Mehta NN, Dey AK, Maddineni R, Kraus WE, Huffman KM. GlycA measured by NMR spectroscopy is associated with disease activity and cardiovascular disease risk in chronic inflammatory diseases. Am J Prev Cardiol 2020;4:100120. [PMID: 34327480 DOI: 10.1016/j.ajpc.2020.100120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
264 Ibarra F, Loi K, Vu AW. Safety and Efficacy of Various Intravenous Insulin Infusion Rates in Patients With and Without Diabetes Presenting With Hypertriglyceridemia. Ann Pharmacother. [DOI: 10.1177/10600280211070102] [Reference Citation Analysis]
265 Murthy VL, Reis JP, Pico AR, Kitchen R, Lima JAC, Lloyd-Jones D, Allen NB, Carnethon M, Lewis GD, Nayor M, Vasan RS, Freedman JE, Clish CB, Shah RV. Comprehensive Metabolic Phenotyping Refines Cardiovascular Risk in Young Adults. Circulation 2020;142:2110-27. [PMID: 33073606 DOI: 10.1161/CIRCULATIONAHA.120.047689] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
266 Whelton SP, Marshall CH, Cainzos-Achirica M, Dzaye O, Blumenthal RS, Nasir K, McClelland RL, Blaha MJ. Pooled Cohort Equations and the competing risk of cardiovascular disease versus cancer: Multi-Ethnic study of atherosclerosis. Am J Prev Cardiol 2021;7:100212. [PMID: 34611644 DOI: 10.1016/j.ajpc.2021.100212] [Reference Citation Analysis]
267 Mehta A, Pandey A, Ayers CR, Khera A, Sperling LS, Szklo MS, Gottesman RF, Budoff MJ, Blaha MJ, Blumenthal RS, Nasir K, Joshi PH. Predictive Value of Coronary Artery Calcium Score Categories for Coronary Events Versus Strokes: Impact of Sex and Race: MESA and DHS. Circ Cardiovasc Imaging 2020;13:e010153. [PMID: 32806939 DOI: 10.1161/CIRCIMAGING.119.010153] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
268 Ahmad MI, Shapiro MD. Preventing Diabetes and Atherosclerosis in the Cardiometabolic Syndrome. Curr Atheroscler Rep 2021;23:16. [PMID: 33686460 DOI: 10.1007/s11883-021-00913-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
269 Walldius G, de Faire U, Alfredsson L, Leander K, Westerholm P, Malmström H, Ivert T, Hammar N. Long-term risk of a major cardiovascular event by apoB, apoA-1, and the apoB/apoA-1 ratio-Experience from the Swedish AMORIS cohort: A cohort study. PLoS Med 2021;18:e1003853. [PMID: 34851955 DOI: 10.1371/journal.pmed.1003853] [Reference Citation Analysis]
270 Muthiah MD, Sanyal AJ. Current management of non-alcoholic steatohepatitis. Liver Int. 2020;40 Suppl 1:89-95. [PMID: 32077609 DOI: 10.1111/liv.14355] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
271 AlQuaiz AM, Kazi A, Youssef RM, Alshehri N, Alduraywish SA. Association between standardized vitamin 25(OH)D and dyslipidemia: a community-based study in Riyadh, Saudi Arabia. Environ Health Prev Med 2020;25:4. [PMID: 31941477 DOI: 10.1186/s12199-019-0841-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
272 Zhao Y, Naumova EN, Bobb JF, Claus Henn B, Singh GM. Joint Associations of Multiple Dietary Components With Cardiovascular Disease Risk: A Machine-Learning Approach. Am J Epidemiol 2021;190:1353-65. [PMID: 33521815 DOI: 10.1093/aje/kwab004] [Reference Citation Analysis]
273 Califf RM. Balanced Dysfunction in the Healthcare Ecosystem Harms Patients. Circulation 2019;140:1860-4. [PMID: 31790300 DOI: 10.1161/CIRCULATIONAHA.119.043935] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
274 Damiri B, Khatib O, Nazzal Z, Sanduka D, Igbaria S, Thabaleh A, Farhoud A, Saudi L, Belkebir S, Al Ali R, Alili M, Hamdan M, Safarini OA, Younis O. Metabolic Syndrome Associated with Tobacco and Caffeine Products Use Among Refugee Adolescents: Risk of Dyslipidemia. Diabetes Metab Syndr Obes 2021;14:4121-33. [PMID: 34616165 DOI: 10.2147/DMSO.S329675] [Reference Citation Analysis]
275 Doose M, Tsui J, Steinberg MB, Xing CY, Lin Y, Cantor JC, Hong CC, Demissie K, Bandera EV. Patterns of chronic disease management and health outcomes in a population-based cohort of Black women with breast cancer. Cancer Causes Control 2021;32:157-68. [PMID: 33404907 DOI: 10.1007/s10552-020-01370-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
276 Luo J, Dancel E, Bains S, Fanikos P, Fischer MA. Academic Detailing in the New Era of Diabetes Medication Management. Curr Diab Rep 2019;19:140. [PMID: 31754838 DOI: 10.1007/s11892-019-1252-0] [Reference Citation Analysis]
277 Tuñón J, Steg PG, Bhatt DL, Bittner VA, Díaz R, Goodman SG, Jukema JW, Kim YU, Li QH, Mueller C, Parkhomenko A, Pordy R, Sritara P, Szarek M, White HD, Zeiher AM, Schwartz GG; ODYSSEY OUTCOMES Investigators. Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial. Eur Heart J 2020;41:4114-23. [PMID: 32820320 DOI: 10.1093/eurheartj/ehaa498] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
278 Garg A, Fazio S, Duell PB, Baass A, Udata C, Joh T, Riel T, Sirota M, Dettling D, Liang H, Garzone PD, Gumbiner B, Wan H. Molecular Characterization of Familial Hypercholesterolemia in a North American Cohort. J Endocr Soc 2020;4:bvz015. [PMID: 31993549 DOI: 10.1210/jendso/bvz015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
279 Kathariya G, Aggarwal J, Garg P, Singh S, Manzoor S. Is evaluation of non-HDL-C better than calculated LDL-C in CAD patients? MMIMSR experiences. Indian Heart J 2020;72:189-91. [PMID: 32768019 DOI: 10.1016/j.ihj.2020.05.008] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
280 Huang W, Lim LMH, Aurangzeb AS, Wong CJ, Koh NSY, Huang Z, Teo HK, Chua TSJ, Tan SY. Performance of the coronary calcium score in an outpatient chest pain clinic and strategies for risk stratification. Clin Cardiol 2021;44:267-75. [PMID: 33434373 DOI: 10.1002/clc.23539] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
281 Shafter AM, Shaikh K, Johanis A, Budoff MJ. De-risking primary prevention: role of imaging. Ther Adv Cardiovasc Dis 2021;15:17539447211051248. [PMID: 34821189 DOI: 10.1177/17539447211051248] [Reference Citation Analysis]
282 Wichaiyo S, Supharattanasitthi W. Bempedoic Acid: A New Non-statin Drug for the Treatment of Dyslipidemia. Clin Drug Investig 2021;41:843-51. [PMID: 34435333 DOI: 10.1007/s40261-021-01075-w] [Reference Citation Analysis]
283 Bu T, Li Z, Hou Y, Sun W, Zhang R, Zhao L, Wei M, Yang G, Yuan L. Exosome-mediated delivery of inflammation-responsive Il-10 mRNA for controlled atherosclerosis treatment. Theranostics 2021;11:9988-10000. [PMID: 34815799 DOI: 10.7150/thno.64229] [Reference Citation Analysis]
284 Gylling H, Strandberg TE, Kovanen PT, Simonen P. Lowering Low-Density Lipoprotein Cholesterol Concentration with Plant Stanol Esters to Reduce the Risk of Atherosclerotic Cardiovascular Disease Events at a Population Level: A Critical Discussion. Nutrients 2020;12:E2346. [PMID: 32781511 DOI: 10.3390/nu12082346] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
285 Sampson M, Ballout RA, Soffer D, Wolska A, Wilson S, Meeusen J, Donato LJ, Fatica E, Otvos JD, Brinton EA, Rosenson RS, Wilson P, Amar M, Shamburek R, Karathanasis SK, Remaley AT. A new phenotypic classification system for dyslipidemias based on the standard lipid panel. Lipids Health Dis 2021;20:170. [PMID: 34838008 DOI: 10.1186/s12944-021-01585-8] [Reference Citation Analysis]
286 Huded CP, Shah NP, Puri R, Nicholls SJ, Wolski K, Nissen SE, Cho L. Association of Serum Lipoprotein (a) Levels and Coronary Atheroma Volume by Intravascular Ultrasound. J Am Heart Assoc 2020;9:e018023. [PMID: 33222598 DOI: 10.1161/JAHA.120.018023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
287 Rodriguez F, Chung S, Blum MR, Coulet A, Basu S, Palaniappan LP. Atherosclerotic Cardiovascular Disease Risk Prediction in Disaggregated Asian and Hispanic Subgroups Using Electronic Health Records. J Am Heart Assoc 2019;8:e011874. [PMID: 31291803 DOI: 10.1161/JAHA.118.011874] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
288 Hessami K, Kasraeian M, Asadi N, Vafaei H, Foroughinia L. Association of Maternal and Umbilical Cord Blood Lipid Parameters with Uterine and Fetal-Placental Blood Flow in Hypertensive and Normotensive Pregnancies. Int J Womens Health 2020;12:115-25. [PMID: 32184675 DOI: 10.2147/IJWH.S233029] [Reference Citation Analysis]
289 Huang YY, Tian WB, Jiang CQ, Zhang WS, Zhu F, Jin YL, Lam TH, Xu L, Cheng KK. A Simple Model for Predicting 10-Year Cardiovascular Risk in Middle-Aged to Older Chinese: Guangzhou Biobank Cohort Study. J Cardiovasc Transl Res 2021. [PMID: 34402029 DOI: 10.1007/s12265-021-10163-3] [Reference Citation Analysis]
290 Bai F, Chen J, Pandey D, Durazo-Arvizu R, Talavera GA, Allison MA, Perreira KM, Schneiderman N, Sutherland MW, Cai J, Daviglus ML, Testai FD. Stroke Risk Factor Status and Use of Stroke Prevention Medications Among Hispanic/Latino Adults in HCHS/SOL. Stroke 2021;52:1339-46. [PMID: 33657859 DOI: 10.1161/STROKEAHA.120.031216] [Reference Citation Analysis]
291 Blaha MJ, Cainzos-Achirica M, Dardari Z, Blankstein R, Shaw LJ, Rozanski A, Rumberger JA, Dzaye O, Michos ED, Berman DS, Budoff MJ, Miedema MD, Blumenthal RS, Nasir K. All-cause and cause-specific mortality in individuals with zero and minimal coronary artery calcium: A long-term, competing risk analysis in the Coronary Artery Calcium Consortium. Atherosclerosis 2020;294:72-9. [PMID: 31784032 DOI: 10.1016/j.atherosclerosis.2019.11.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
292 Brunner FJ, Waldeyer C, Ojeda F, Salomaa V, Kee F, Sans S, Thorand B, Giampaoli S, Brambilla P, Tunstall-Pedoe H, Moitry M, Iacoviello L, Veronesi G, Grassi G, Mathiesen EB, Söderberg S, Linneberg A, Brenner H, Amouyel P, Ferrières J, Tamosiunas A, Nikitin YP, Drygas W, Melander O, Jöckel KH, Leistner DM, Shaw JE, Panagiotakos DB, Simons LA, Kavousi M, Vasan RS, Dullaart RPF, Wannamethee SG, Risérus U, Shea S, de Lemos JA, Omland T, Kuulasmaa K, Landmesser U, Blankenberg S; Multinational Cardiovascular Risk Consortium. Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium. Lancet 2019;394:2173-83. [PMID: 31810609 DOI: 10.1016/S0140-6736(19)32519-X] [Cited by in Crossref: 61] [Cited by in F6Publishing: 33] [Article Influence: 20.3] [Reference Citation Analysis]
293 Curtis JR, Xie F, Crowson CS, Sasso EH, Hitraya E, Chin CL, Bamford RD, Ben-Shachar R, Gutin A, Flake DD 2nd, Mabey B, Lanchbury JS. Derivation and internal validation of a multi-biomarker-based cardiovascular disease risk prediction score for rheumatoid arthritis patients. Arthritis Res Ther 2020;22:282. [PMID: 33276814 DOI: 10.1186/s13075-020-02355-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
294 Cho SY, Kim SH, Kang SH, Lee KJ, Choi D, Kang S, Park SJ, Kim T, Yoon CH, Youn TJ, Chae IH. Pre-existing and machine learning-based models for cardiovascular risk prediction. Sci Rep 2021;11:8886. [PMID: 33903629 DOI: 10.1038/s41598-021-88257-w] [Reference Citation Analysis]
295 Nappi C, Gaudieri V, Cuocolo A. Computed tomography calls out nuclear imaging in its field: It doesn't matter how you are searching but what you are looking for. J Nucl Cardiol 2021;28:1715-7. [PMID: 31646470 DOI: 10.1007/s12350-019-01926-2] [Reference Citation Analysis]
296 Stehlik J, Kemeyou L. Protecting the Heart Allograft With a Statin. Circulation 2019;140:641-4. [PMID: 31424991 DOI: 10.1161/CIRCULATIONAHA.119.042016] [Reference Citation Analysis]
297 Kim K, Lee SH. Effects of Statins for Primary Prevention in the Elderly: Recent Evidence. J Lipid Atheroscler 2020;9:1-7. [PMID: 32821718 DOI: 10.12997/jla.2020.9.1.1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
298 DeJongh BM. Clinical pearls for the monitoring and treatment of antipsychotic induced metabolic syndrome. Ment Health Clin 2021;11:311-9. [PMID: 34824956 DOI: 10.9740/mhc.2021.11.311] [Reference Citation Analysis]
299 Nelson AJ, Ardissino M, Haynes K, Shambhu S, Eapen ZJ, McGuire DK, Carnicelli A, Lopes RD, Green JB, O'Brien EC, Pagidipati NJ, Granger CB. Gaps in Evidence-Based Therapy Use in Insured Patients in the United States With Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease. J Am Heart Assoc 2021;10:e016835. [PMID: 33432843 DOI: 10.1161/JAHA.120.016835] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
300 Kim J, Kang D, Park H, Kang M, Choi KH, Park TK, Lee JM, Yang JH, Song YB, Choi JH, Choi SH, Gwon HC, Guallar E, Cho J, Hahn JY. Moderate-Intensity Statins Plus Ezetimibe vs. High-Intensity Statins After Coronary Revascularization: A Cohort Study. Cardiovasc Drugs Ther 2021. [PMID: 34533691 DOI: 10.1007/s10557-021-07256-1] [Reference Citation Analysis]
301 Pishgar F, Shabani M, Quinaglia A C Silva T, Bluemke DA, Budoff M, Barr RG, Allison MA, Bertoni AG, Post WS, Lima JAC, Demehri S. Adipose tissue biomarkers and type 2 diabetes incidence in normoglycemic participants in the MESArthritis Ancillary Study: A cohort study. PLoS Med 2021;18:e1003700. [PMID: 34242221 DOI: 10.1371/journal.pmed.1003700] [Reference Citation Analysis]
302 Rosenson RS, Hubbard D, Monda KL, Reading SR, Chen L, Dluzniewski PJ, Burkholder GA, Muntner P, Colantonio LD. Excess Risk for Atherosclerotic Cardiovascular Outcomes Among US Adults With HIV in the Current Era. J Am Heart Assoc 2020;9:e013744. [PMID: 31880980 DOI: 10.1161/JAHA.119.013744] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
303 Kim H, Kim IC, Hwang J, Lee CH, Cho YK, Park HS, Chung JW, Nam CW, Han S, Hur SH. Features and implications of higher systolic central than peripheral blood pressure in patients at very high risk of atherosclerotic cardiovascular disease. J Hum Hypertens 2021. [PMID: 33408327 DOI: 10.1038/s41371-020-00472-6] [Reference Citation Analysis]
304 Liday C, Kirkpatrick C. Optimal Dietary Strategies for Prevention of Atherosclerotic Cardiovascular Disease in Diabetes: Evidence and Recommendations. Curr Cardiol Rep 2019;21:132. [PMID: 31624930 DOI: 10.1007/s11886-019-1232-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
305 Alonso R, Perez de Isla L, Muñiz-Grijalvo O, Mata P. Barriers to Early Diagnosis and Treatment of Familial Hypercholesterolemia: Current Perspectives on Improving Patient Care. Vasc Health Risk Manag 2020;16:11-25. [PMID: 32021224 DOI: 10.2147/VHRM.S192401] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
306 Khera R, Pandey A, Ayers CR, Carnethon MR, Greenland P, Ndumele CE, Nambi V, Seliger SL, Chaves PHM, Safford MM, Cushman M, Xanthakis V, Vasan RS, Mentz RJ, Correa A, Lloyd-Jones DM, Berry JD, de Lemos JA, Neeland IJ. Performance of the Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Body Mass Index. JAMA Netw Open 2020;3:e2023242. [PMID: 33119108 DOI: 10.1001/jamanetworkopen.2020.23242] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
307 Feldman DI, Michos ED, Stone NJ, Gluckman TJ, Cainzos-Achirica M, Virani SS, Blumenthal RS. Same evidence, varying viewpoints: Three questions illustrating important differences between United States and European cholesterol guideline recommendations. Am J Prev Cardiol 2020;4:100117. [PMID: 34327477 DOI: 10.1016/j.ajpc.2020.100117] [Reference Citation Analysis]
308 Hahn J, Dehghan M, Drouin-chartier J, Mentz RJ, Jneid H, Virani SS, Tang WHW, Krittanawong C. Egg Consumption and Risk of Cardiovascular Disease: a Critical Review. Curr Emerg Hosp Med Rep 2021;9:25-37. [DOI: 10.1007/s40138-021-00225-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
309 Aday AW, Matsushita K. Epidemiology of Peripheral Artery Disease and Polyvascular Disease. Circ Res 2021;128:1818-32. [PMID: 34110907 DOI: 10.1161/CIRCRESAHA.121.318535] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
310 Aengevaeren VL, Mosterd A, Sharma S, Prakken NHJ, Möhlenkamp S, Thompson PD, Velthuis BK, Eijsvogels TMH. Exercise and Coronary Atherosclerosis: Observations, Explanations, Relevance, and Clinical Management. Circulation 2020;141:1338-50. [PMID: 32310695 DOI: 10.1161/CIRCULATIONAHA.119.044467] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
311 Eng D, Chute C, Khandwala N, Rajpurkar P, Long J, Shleifer S, Khalaf MH, Sandhu AT, Rodriguez F, Maron DJ, Seyyedi S, Marin D, Golub I, Budoff M, Kitamura F, Takahashi MS, Filice RW, Shah R, Mongan J, Kallianos K, Langlotz CP, Lungren MP, Ng AY, Patel BN. Automated coronary calcium scoring using deep learning with multicenter external validation. NPJ Digit Med 2021;4:88. [PMID: 34075194 DOI: 10.1038/s41746-021-00460-1] [Reference Citation Analysis]
312 Haslam DE, Peloso GM, Herman MA, Dupuis J, Lichtenstein AH, Smith CE, McKeown NM. Beverage Consumption and Longitudinal Changes in Lipoprotein Concentrations and Incident Dyslipidemia in US Adults: The Framingham Heart Study. J Am Heart Assoc 2020;9:e014083. [PMID: 32098600 DOI: 10.1161/JAHA.119.014083] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
313 Kim H, Lee CJ, Choi D, Kim BK, Kim IC, Kim JS, Ahn CM, Hong GR, Cho IJ, Shim CY, Lee SH. Lipid-Lowering Efficacy and Safety of a New Generic Rosuvastatin in Koreans: an 8-Week Randomized Comparative Study with a Proprietary Rosuvastatin. J Lipid Atheroscler 2020;9:283-90. [PMID: 32821737 DOI: 10.12997/jla.2020.9.2.283] [Reference Citation Analysis]
314 Derington CG, Colantonio LD, Herrick JS, Cook J, King JB, Rosenson RS, Poudel B, Monda KL, Navar AM, Mues KE, Stevens VW, Nelson RE, Vanneman ME, Muntner P, Bress AP. Factors Associated With PCSK9 Inhibitor Initiation Among US Veterans. J Am Heart Assoc 2021;10:e019254. [PMID: 33821686 DOI: 10.1161/JAHA.120.019254] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
315 Leucker TM, Blaha MJ, Jones SR, Vavuranakis MA, Williams MS, Lai H, Schindler TH, Latina J, Schulman SP, Gerstenblith G. Effect of Evolocumab on Atherogenic Lipoproteins During the Peri- and Early Postinfarction Period: A Placebo-Controlled, Randomized Trial. Circulation 2020;142:419-21. [PMID: 32718248 DOI: 10.1161/CIRCULATIONAHA.120.046320] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
316 Rymer JA, Mues KE, Monda KL, Bratton EW, Wirtz HS, Okerson T, Overman RA, Brookhart MA, Muntner P, Wang TY. Use of Low-Density Lipoprotein-Lowering Therapies Before and After PCSK9 Inhibitor Initiation. J Am Heart Assoc 2020;9:e014347. [PMID: 32326795 DOI: 10.1161/JAHA.119.014347] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
317 Senguttuvan NB, Subramanian V, Venkatesan V, Muralidharan TR, Sankaranarayanan K. Clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular diseases-an updated systematic review. J Genet Eng Biotechnol 2021;19:105. [PMID: 34279740 DOI: 10.1186/s43141-021-00205-3] [Reference Citation Analysis]
318 Shea S, Navas-Acien A, Shimbo D, Brown ER, Budoff M, Bancks MP, Barr RG, Kronmal R. Spatially Weighted Coronary Artery Calcium Score and Coronary Heart Disease Events in the Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Imaging 2021;14:e011981. [PMID: 33461306 DOI: 10.1161/CIRCIMAGING.120.011981] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
319 Mszar R, Gopal DJ, Chowdary R, Smith CL, Dolin CD, Irwin ML, Soffer D, Nemiroff R, Lewey J. Racial/Ethnic Disparities in Screening for and Awareness of High Cholesterol Among Pregnant Women Receiving Prenatal Care. J Am Heart Assoc 2021;10:e017415. [PMID: 33345544 DOI: 10.1161/JAHA.120.017415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
320 Toth PP, Jones SR, Monsalvo ML, Elliott-Davey M, López JAG, Banach M. Effect of Evolocumab on Non-High-Density Lipoprotein Cholesterol, Apolipoprotein B, and Lipoprotein(a): A Pooled Analysis of Phase 2 and Phase 3 Studies. J Am Heart Assoc 2020;9:e014129. [PMID: 32114889 DOI: 10.1161/JAHA.119.014129] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 5.5] [Reference Citation Analysis]
321 Gencer B, Giugliano RP. Management of LDL-cholesterol after an acute coronary syndrome: Key comparisons of the American and European clinical guidelines to the attention of the healthcare providers. Clin Cardiol 2020;43:684-90. [PMID: 32596859 DOI: 10.1002/clc.23410] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
322 Grantz KL, Elmi A, Pugh SJ, Catov J, Sjaarda L, Albert PS. Maternal Serum Lipid Trajectories and Association with Pregnancy Loss and Length of Gestation. Am J Perinatol 2020;37:914-23. [PMID: 31154664 DOI: 10.1055/s-0039-1689000] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
323 Tremonti C, Thieben M. Drugs in secondary stroke prevention. Aust Prescr 2021;44:85-90. [PMID: 34211246 DOI: 10.18773/austprescr.2021.018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
324 Kovacevic MP, Dube KM, Lupi KE, Szumita PM, DeGrado JR. Evaluation of Hypertriglyceridemia in Critically Ill Patients With Coronavirus Disease 2019 Receiving Propofol. Crit Care Explor 2021;3:e0330. [PMID: 33490957 DOI: 10.1097/CCE.0000000000000330] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
325 Wallace AS, Wang D, Shin JI, Selvin E. Screening and Diagnosis of Prediabetes and Diabetes in US Children and Adolescents. Pediatrics 2020;146:e20200265. [PMID: 32778539 DOI: 10.1542/peds.2020-0265] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
326 Sánchez Macarro M, Martínez Rodríguez JP, Bernal Morell E, Pérez-Piñero S, Victoria-Montesinos D, García-Muñoz AM, Cánovas García F, Castillo Sánchez J, López-Román FJ. Effect of a Combination of Citrus Flavones and Flavanones and Olive Polyphenols for the Reduction of Cardiovascular Disease Risk: An Exploratory Randomized, Double-Blind, Placebo-Controlled Study in Healthy Subjects. Nutrients 2020;12:E1475. [PMID: 32438719 DOI: 10.3390/nu12051475] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
327 Chen LW, Lin CS, Tsai MC, Shih SF, Lim ZW, Chen SJ, Tsui PF, Ho LJ, Lai JH, Liou JT. Pitavastatin Exerts Potent Anti-Inflammatory and Immunomodulatory Effects via the Suppression of AP-1 Signal Transduction in Human T Cells. Int J Mol Sci 2019;20:E3534. [PMID: 31330988 DOI: 10.3390/ijms20143534] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
328 Lin SY, Baumann K, Zhou C, Zhou W, Cuellar AE, Xue H. Trends in Use and Expenditures for Brand-name Statins After Introduction of Generic Statins in the US, 2002-2018. JAMA Netw Open 2021;4:e2135371. [PMID: 34807258 DOI: 10.1001/jamanetworkopen.2021.35371] [Reference Citation Analysis]
329 Koirala B, Turkson-Ocran RA, Baptiste D, Koirala B, Francis L, Davidson P, Himmelfarb CD, Commodore-Mensah Y. Heterogeneity of Cardiovascular Disease Risk Factors Among Asian Immigrants: Insights From the 2010 to 2018 National Health Interview Survey. J Am Heart Assoc 2021;10:e020408. [PMID: 34182790 DOI: 10.1161/JAHA.120.020408] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
330 Dorsch MP, Lester CA, Ding Y, Joseph M, Brook RD. Effects of Race on Statin Prescribing for Primary Prevention With High Atherosclerotic Cardiovascular Disease Risk in a Large Healthcare System. J Am Heart Assoc 2019;8:e014709. [PMID: 31707943 DOI: 10.1161/JAHA.119.014709] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
331 Wong ND, Zhao Y, Sung J, Browne A. Relation of First and Total Recurrent Atherosclerotic Cardiovascular Disease Events to Increased Lipoprotein(a) Levels Among Statin Treated Adults With Cardiovascular Disease. Am J Cardiol 2021;145:12-7. [PMID: 33454339 DOI: 10.1016/j.amjcard.2020.12.075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
332 Nguyen I, Kim AS, Chow FC. Prevention of stroke in people living with HIV. Prog Cardiovasc Dis 2020;63:160-9. [PMID: 32014514 DOI: 10.1016/j.pcad.2020.01.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
333 Batrakoulis A, Jamurtas AZ, Draganidis D, Georgakouli K, Tsimeas P, Poulios A, Syrou N, Deli CK, Papanikolaou K, Tournis S, Fatouros IG. Hybrid Neuromuscular Training Improves Cardiometabolic Health and Alters Redox Status in Inactive Overweight and Obese Women: A Randomized Controlled Trial. Antioxidants (Basel) 2021;10:1601. [PMID: 34679738 DOI: 10.3390/antiox10101601] [Reference Citation Analysis]
334 Shugg T, Pasternak AL, London B, Luzum JA. Prevalence and types of inconsistencies in clinical pharmacogenetic recommendations among major U.S. sources. NPJ Genom Med 2020;5:48. [PMID: 33145028 DOI: 10.1038/s41525-020-00156-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
335 Ma S, Xia M, Gao X. Biomarker Discovery in Atherosclerotic Diseases Using Quantitative Nuclear Magnetic Resonance Metabolomics. Front Cardiovasc Med 2021;8:681444. [PMID: 34395555 DOI: 10.3389/fcvm.2021.681444] [Reference Citation Analysis]
336 Cainzos-Achirica M, Miedema MD, McEvoy JW, Al Rifai M, Greenland P, Dardari Z, Budoff M, Blumenthal RS, Yeboah J, Duprez DA, Mortensen MB, Dzaye O, Hong J, Nasir K, Blaha MJ. Coronary Artery Calcium for Personalized Allocation of Aspirin in Primary Prevention of Cardiovascular Disease in 2019: The MESA Study (Multi-Ethnic Study of Atherosclerosis). Circulation 2020;141:1541-53. [PMID: 32233663 DOI: 10.1161/CIRCULATIONAHA.119.045010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 5] [Article Influence: 13.0] [Reference Citation Analysis]
337 Li YH, Sheu WH, Yeh WC, Chang YC, Lee IT. Predicting Long-Term Mortality in Patients with Angina across the Spectrum of Dysglycemia: A Machine Learning Approach. Diagnostics (Basel) 2021;11:1060. [PMID: 34207578 DOI: 10.3390/diagnostics11061060] [Reference Citation Analysis]
338 Rippe JM. Lifestyle Medicine: A Critical Key to Restoring Health. Am J Lifestyle Med 2021;15:484-6. [PMID: 34646093 DOI: 10.1177/15598276211008394] [Reference Citation Analysis]
339 Gencer B, Marston NA, Im K, Cannon CP, Sever P, Keech A, Braunwald E, Giugliano RP, Sabatine MS. Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials. Lancet 2020;396:1637-43. [PMID: 33186535 DOI: 10.1016/S0140-6736(20)32332-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 6] [Article Influence: 13.5] [Reference Citation Analysis]
340 C Thambiah S, Lai LC. Diabetic dyslipidaemia. Pract Lab Med 2021;26:e00248. [PMID: 34368411 DOI: 10.1016/j.plabm.2021.e00248] [Reference Citation Analysis]
341 Daviglus ML, Ferdinand KC, López JAG, Wu Y, Monsalvo ML, Rodriguez CJ. Effects of Evolocumab on Low-Density Lipoprotein Cholesterol, Non-High Density Lipoprotein Cholesterol, Apolipoprotein B, and Lipoprotein(a) by Race and Ethnicity: A Meta-Analysis of Individual Participant Data From Double-Blind and Open-Label Extension Studies. J Am Heart Assoc 2021;10:e016839. [PMID: 33325247 DOI: 10.1161/JAHA.120.016839] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
342 Johnson HM, Gorre CE, Friedrich-Karnik A, Gulati M. Addressing the Bias in Cardiovascular Care: Missed & Delayed Diagnosis of Cardiovascular Disease in Women. Am J Prev Cardiol 2021;8:100299. [PMID: 34917995 DOI: 10.1016/j.ajpc.2021.100299] [Reference Citation Analysis]
343 Gumuser ED, Haidermota S, Finneran P, Natarajan P, Honigberg MC. Trends in cholesterol testing during the COVID-19 pandemic: COVID-19 and cholesterol testing. Am J Prev Cardiol 2021;6:100152. [PMID: 33778798 DOI: 10.1016/j.ajpc.2021.100152] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
344 Agarwala A, Michos ED, Samad Z, Ballantyne CM, Virani SS. The Use of Sex-Specific Factors in the Assessment of Women's Cardiovascular Risk. Circulation 2020;141:592-9. [PMID: 32065772 DOI: 10.1161/CIRCULATIONAHA.119.043429] [Cited by in Crossref: 31] [Cited by in F6Publishing: 14] [Article Influence: 15.5] [Reference Citation Analysis]
345 Sajja A, Park J, Sathiyakumar V, Varghese B, Pallazola VA, Marvel FA, Kulkarni K, Muthukumar A, Joshi PH, Gianos E, Hirsh B, Mintz G, Goldberg A, Morris PB, Sharma G, Blumenthal RS, Michos ED, Post WS, Elshazly MB, Jones SR, Martin SS. Comparison of Methods to Estimate Low-Density Lipoprotein Cholesterol in Patients With High Triglyceride Levels. JAMA Netw Open 2021;4:e2128817. [PMID: 34709388 DOI: 10.1001/jamanetworkopen.2021.28817] [Reference Citation Analysis]
346 Parhofer KG, Chapman MJ, Nordestgaard BG. Efficacy and safety of icosapent ethyl in hypertriglyceridaemia: a recap. Eur Heart J Suppl 2020;22:J21-33. [PMID: 33061865 DOI: 10.1093/eurheartj/suaa116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
347 Cassagnol M, Hai O, Sherali SA, D’Angelo K, Bass D, Zeltser R, Makaryus AN. Impact of cardiologist intervention on guideline-directed use of statin therapy. World J Cardiol 2020; 12(8): 419-426 [PMID: 32879704 DOI: 10.4330/wjc.v12.i8.419] [Reference Citation Analysis]
348 Shroff H, VanWagner LB. Cardiovascular Disease in Nonalcoholic Steatohepatitis: Screening and Management. Curr Hepatol Rep. 2020;19:315-326. [PMID: 33585157 DOI: 10.1007/s11901-020-00530-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
349 Behbodikhah J, Ahmed S, Elyasi A, Kasselman LJ, De Leon J, Glass AD, Reiss AB. Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target. Metabolites 2021;11:690. [PMID: 34677405 DOI: 10.3390/metabo11100690] [Reference Citation Analysis]
350 Choi KH, Seo WK, Park MS, Kim JT, Chung JW, Bang OY, Kim GM, Song TJ, Kim BJ, Heo SH, Jung JM, Oh KM, Kim CK, Yu S, Park KY, Kim JM, Park JH, Choi JC, Hwang YH, Kim YJ. Effect of Statin Therapy on Outcomes of Patients With Acute Ischemic Stroke and Atrial Fibrillation. J Am Heart Assoc 2019;8:e013941. [PMID: 31826725 DOI: 10.1161/JAHA.119.013941] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
351 Xia X, Liu F, Yang X, Li J, Chen J, Liu X, Cao J, Shen C, Yu L, Zhao Y, Wu X, Zhao L, Li Y, Huang J, Lu X, Gu D. Associations of egg consumption with incident cardiovascular disease and all-cause mortality. Sci China Life Sci 2020;63:1317-27. [PMID: 32170624 DOI: 10.1007/s11427-020-1656-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
352 Ullmo J, Cruz-Lemini M, Sánchez-García O, Bos-Real L, Fernandez De La Llama P, Calero F, Domínguez-Gallardo C, Garrido-Gimenez C, Trilla C, Carreras-Costa F, Sionis A, Mora J, García-Osuna Á, Ordoñez-Llanos J, Llurba E. Cardiac dysfunction and remodeling regulated by anti-angiogenic environment in patients with preeclampsia: the ANGIOCOR prospective cohort study protocol. BMC Pregnancy Childbirth 2021;21:816. [PMID: 34879854 DOI: 10.1186/s12884-021-04263-w] [Reference Citation Analysis]
353 Banach M, Burchardt P, Chlebus K, Dobrowolski P, Dudek D, Dyrbuś K, Gąsior M, Jankowski P, Jóźwiak J, Kłosiewicz-Latoszek L, Kowalska I, Małecki M, Prejbisz A, Rakowski M, Rysz J, Solnica B, Sitkiewicz D, Sygitowicz G, Sypniewska G, Tomasik T, Windak A, Zozulińska-Ziółkiewicz D, Cybulska B. PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021. Arch Med Sci 2021;17:1447-547. [PMID: 34900032 DOI: 10.5114/aoms/141941] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
354 Nguyen D, Du N, Sulaica EM, Wanat MA. Bempedoic Acid: A New Drug for an Old Problem. Ann Pharmacother 2021;55:246-51. [PMID: 32674598 DOI: 10.1177/1060028020941083] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
355 Furtado RHM, Genestreti PR, Dalçóquio TF, Baracioli LM, Lima FG, Franci A, Giraldez RRCV, Menezes FR, Ferrari AG, Lima VM, Pereira CAC, Nakashima CAK, Salsoso R, Godoy LC, Nicolau JC. Association between Statin Therapy and Lower Incidence of Hyperglycemia in Patients Hospitalized with Acute Coronary Syndromes. Arq Bras Cardiol 2021;116:285-94. [PMID: 33656078 DOI: 10.36660/abc.20200128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
356 Butalia S, Lee-Krueger RCW, McBrien KA, Leung AAC, Anderson TJ, Quan H, Naugler C, Chen G, Campbell DJT. Barriers and Facilitators to Using Statins: A Qualitative Study With Patients and Family Physicians. CJC Open 2020;2:530-8. [PMID: 33305213 DOI: 10.1016/j.cjco.2020.07.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
357 Flores Rosario K, Mehta A, Ayers C, Engel Gonzalez P, Pandey A, Khera R, Kaplan R, Blaha MJ, Khera A, Blumenthal RS, Nasir K, Rodriguez CJ, Joshi PH. Performance of the Pooled Cohort Equations in Hispanic Individuals Across the United States: Insights From the Multi-Ethnic Study of Atherosclerosis and the Dallas Heart Study. J Am Heart Assoc 2021;10:e018410. [PMID: 33870702 DOI: 10.1161/JAHA.120.018410] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
358 Aggarwal DJ, Kathariya MG, Verma DPK. LDL-C, NON-HDL-C and APO-B for cardiovascular risk assessment: Looking for the ideal marker. Indian Heart J 2021;73:544-8. [PMID: 34627566 DOI: 10.1016/j.ihj.2021.07.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
359 Koh N, Ference BA, Nicholls SJ, Navar AM, Chew DP, Kostner K, He B, Tse HF, Dalal J, Santoso A, Ako J, Tada H, Park JJ, Ong ML, Lim E, Subramaniam T, Li YH, Phrommintikul A, Iyengar SS, Ray S, Park KW, Tan HC, Chunhamaneewat N, Yeo KK, Tan JWC. Asian Pacific Society of Cardiology Consensus Recommendations on Dyslipidaemia. Eur Cardiol 2021;16:e54. [PMID: 35024056 DOI: 10.15420/ecr.2021.36] [Reference Citation Analysis]
360 Bianchini M, Puliani G, Chiefari A, Mormando M, Lauretta R, Appetecchia M. Metabolic and Endocrine Toxicities of Mitotane: A Systematic Review. Cancers (Basel) 2021;13:5001. [PMID: 34638485 DOI: 10.3390/cancers13195001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
361 Evans CR, Long DL, Howard G, McClure LA, Zakai NA, Jenny NS, Kissela BM, Safford MM, Howard VJ, Cushman M. C-reactive protein and stroke risk in blacks and whites: The REasons for Geographic And Racial Differences in Stroke cohort. Am Heart J 2019;217:94-100. [PMID: 31520899 DOI: 10.1016/j.ahj.2019.08.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
362 Gebremedhin MH, Lake EA, Gebrekirstos LG. Heavy khat (Catha edulis) chewing and dyslipidemia as modifiable hypertensive risk factors among patients in Southwest, Ethiopia: Unmatched case-control study. PLoS One 2021;16:e0259078. [PMID: 34699551 DOI: 10.1371/journal.pone.0259078] [Reference Citation Analysis]
363 Aerts N, Le Goff D, Odorico M, Le Reste JY, Van Bogaert P, Peremans L, Musinguzi G, Van Royen P, Bastiaens H. Systematic review of international clinical guidelines for the promotion of physical activity for the primary prevention of cardiovascular diseases. BMC Fam Pract 2021;22:97. [PMID: 34011279 DOI: 10.1186/s12875-021-01409-9] [Reference Citation Analysis]
364 Hu C, Liu J, Han H, Sun Y, Cheng Y, Liu Y, Gao A, Zhou Y, Zhang J, Zhao Y. A Synergistic Effect of Lp(a) and GRACE Score on Cardiovascular Risk in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Cohort Study From China. Front Cardiovasc Med 2021;8:637366. [PMID: 33681307 DOI: 10.3389/fcvm.2021.637366] [Reference Citation Analysis]
365 Schroder J, Jakobsen JC, Winkel P, Hilden J, Jensen GB, Sajadieh A, Larsson A, Ärnlöv J, Harutyunyan M, Johansen JS, Kjøller E, Gluud C, Kastrup J. Prognosis and Reclassification by YKL-40 in Stable Coronary Artery Disease. J Am Heart Assoc 2020;9:e014634. [PMID: 32114892 DOI: 10.1161/JAHA.119.014634] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
366 Furtado RHM, Giugliano RP. What Lessons Have We Learned and What Remains to be Clarified for PCSK9 Inhibitors? A Review of FOURIER and ODYSSEY Outcomes Trials. Cardiol Ther 2020;9:59-73. [PMID: 32026310 DOI: 10.1007/s40119-020-00163-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
367 Perak AM, Ning H, Kit BK, de Ferranti SD, Van Horn LV, Wilkins JT, Lloyd-Jones DM. Trends in Levels of Lipids and Apolipoprotein B in US Youths Aged 6 to 19 Years, 1999-2016. JAMA 2019;321:1895-905. [PMID: 31112258 DOI: 10.1001/jama.2019.4984] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 9.3] [Reference Citation Analysis]
368 Felici N, Liu D, Maret J, Restrepo M, Borovskiy Y, Hajj J, Chung W, Laudanski K. Long-Term Abnormalities of Lipid Profile After a Single Episode of Sepsis. Front Cardiovasc Med 2021;8:674248. [PMID: 34869619 DOI: 10.3389/fcvm.2021.674248] [Reference Citation Analysis]
369 Zhang X, Xing L, Jia X, Pang X, Xiang Q, Zhao X, Ma L, Liu Z, Hu K, Wang Z, Cui Y. Comparative Lipid-Lowering/Increasing Efficacy of 7 Statins in Patients with Dyslipidemia, Cardiovascular Diseases, or Diabetes Mellitus: Systematic Review and Network Meta-Analyses of 50 Randomized Controlled Trials. Cardiovasc Ther 2020;2020:3987065. [PMID: 32411300 DOI: 10.1155/2020/3987065] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
370 Vassy JL, Lu B, Ho YL, Galloway A, Raghavan S, Honerlaw J, Tarko L, Russo J, Qazi S, Orkaby AR, Tanukonda V, Djousse L, Gaziano JM, Gagnon DR, Cho K, Wilson PWF. Estimation of Atherosclerotic Cardiovascular Disease Risk Among Patients in the Veterans Affairs Health Care System. JAMA Netw Open 2020;3:e208236. [PMID: 32662843 DOI: 10.1001/jamanetworkopen.2020.8236] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
371 Schiele F, Pérez de Isla L, Arca M, Vlachopoulos C. Is it Time for Single-Pill Combinations in Dyslipidemia? Am J Cardiovasc Drugs 2021. [PMID: 34549371 DOI: 10.1007/s40256-021-00498-2] [Reference Citation Analysis]
372 Orringer CE, Tokgozoglu L, Maki KC, Ray KK, Saseen JJ, Catapano AL. Transatlantic Lipid Guideline Divergence: Same Data But Different Interpretations. J Am Heart Assoc 2020;9:e018189. [PMID: 33092440 DOI: 10.1161/JAHA.120.018189] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
373 White N. Academic Training, Knowledge, and Perceptions of Physical Activity in Student Pharmacists. Am J Lifestyle Med 2021;15:227-9. [PMID: 34025311 DOI: 10.1177/1559827621989284] [Reference Citation Analysis]
374 Perak AM, Ning H, Khan SS, Van Horn LV, Grobman WA, Lloyd-Jones DM. Cardiovascular Health Among Pregnant Women, Aged 20 to 44 Years, in the United States. J Am Heart Assoc 2020;9:e015123. [PMID: 32063122 DOI: 10.1161/JAHA.119.015123] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
375 Calling S, Johansson SE, Wolff M, Sundquist J, Sundquist K. Total cholesterol/HDL-C ratio versus non-HDL-C as predictors for ischemic heart disease: a 17-year follow-up study of women in southern Sweden. BMC Cardiovasc Disord 2021;21:163. [PMID: 33820540 DOI: 10.1186/s12872-021-01971-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
376 Klein J, Mauck L, Schackert G, Pinzer T. Do statins reduce the rate of revision surgery after chronic subdural hematoma drain? Acta Neurochir (Wien) 2021;163:1843-8. [PMID: 34036461 DOI: 10.1007/s00701-021-04871-7] [Reference Citation Analysis]
377 Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Muñoz D, Smith SC Jr, Virani SS, Williams KA Sr, Yeboah J, Ziaeian B. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019;140:e596-646. [PMID: 30879355 DOI: 10.1161/CIR.0000000000000678] [Cited by in Crossref: 270] [Cited by in F6Publishing: 364] [Article Influence: 90.0] [Reference Citation Analysis]
378 Henson JB, Simon TG, Kaplan A, Osganian S, Masia R, Corey KE. Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2020;51:728-36. [PMID: 32043602 DOI: 10.1111/apt.15660] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 16.0] [Reference Citation Analysis]
379 Richardson TG, Sanderson E, Palmer TM, Ala-Korpela M, Ference BA, Davey Smith G, Holmes MV. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis. PLoS Med 2020;17:e1003062. [PMID: 32203549 DOI: 10.1371/journal.pmed.1003062] [Cited by in Crossref: 95] [Cited by in F6Publishing: 67] [Article Influence: 47.5] [Reference Citation Analysis]
380 Wawruch M, Wimmer G Jr, Murin J, Paduchova M, Tesar T, Hlinkova L, Slavkovsky P, Aarnio E. Factors Associated with Reinitiation of Statin Treatment in Older Patients with Peripheral Arterial Disease. Drugs Aging 2020;37:595-604. [PMID: 32514873 DOI: 10.1007/s40266-020-00772-z] [Reference Citation Analysis]
381 Kohlman-Trigoboff D. Healthcare Inequity in PAD. J Vasc Nurs 2021;39:54-6. [PMID: 34507700 DOI: 10.1016/j.jvn.2021.06.004] [Reference Citation Analysis]
382 Omer L, Hudson EA, Hudgins LC, Boyd NL. Cohort Generation and Characterization of Patient-Specific Familial Hypercholesterolemia Induced Pluripotent Stem Cells. Stem Cells Dev 2021;30:632-40. [PMID: 34029164 DOI: 10.1089/scd.2021.0004] [Reference Citation Analysis]
383 Takaeko Y, Kajikawa M, Kishimoto S, Yamaji T, Harada T, Han Y, Kihara Y, Hida E, Chayama K, Goto C, Aibara Y, Yusoff FM, Maruhashi T, Nakashima A, Higashi Y. Low Levels of Low-Density Lipoprotein Cholesterol and Endothelial Function in Subjects without Lipid-Lowering Therapy. J Clin Med 2020;9:E3796. [PMID: 33255270 DOI: 10.3390/jcm9123796] [Reference Citation Analysis]
384 Feldman DI, Dudum R, Alfaddagh A, Marvel FA, Michos ED, Blumenthal RS, Martin SS. Summarizing 2019 in Cardiovascular Prevention Using the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease's 'ABC's Approach. Am J Prev Cardiol 2020;2:100027. [PMID: 33575672 DOI: 10.1016/j.ajpc.2020.100027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
385 Thongtang N, Piyapromdee J, Tangkittikasem N, Samaithongcharoen K, Srikanchanawat N, Sriussadaporn S. Efficacy and Safety of Switching from Low-Dose Statin to High-Intensity Statin for Primary Prevention in Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Metab Syndr Obes 2020;13:423-31. [PMID: 32110075 DOI: 10.2147/DMSO.S219496] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
386 Zhao B, Wu Q, Wang L, Liao C, Dong Y, Xu J, Wei Y, Zhang W. Pros and Cons of Aspirin for the Primary Prevention of Cardiovascular Events: A Secondary Study of Trial Sequential Analysis. Front Pharmacol 2020;11:592116. [PMID: 33519452 DOI: 10.3389/fphar.2020.592116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
387 Sorbets E, Fox KM, Elbez Y, Danchin N, Dorian P, Ferrari R, Ford I, Greenlaw N, Kalra PR, Parma Z, Shalnova S, Tardif JC, Tendera M, Zamorano JL, Vidal-Petiot E, Steg PG; CLARIFY investigators. Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry. Eur Heart J 2020;41:347-56. [PMID: 31504434 DOI: 10.1093/eurheartj/ehz660] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 21.0] [Reference Citation Analysis]
388 Park K, Minissian MB, Wei J, Saade GR, Smith GN. Contemporary clinical updates on the prevention of future cardiovascular disease in women who experience adverse pregnancy outcomes. Clin Cardiol 2020;43:553-9. [PMID: 32304143 DOI: 10.1002/clc.23374] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
389 Vasquez N, Joshi PH. Lp(a): Addressing a Target for Cardiovascular Disease Prevention. Curr Cardiol Rep 2019;21:102. [PMID: 31367887 DOI: 10.1007/s11886-019-1182-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
390 Truong QA, Villines TC. Risk Scores versus Atherosclerosis Imaging: Time to Embrace What Is in Plain Sight! Radiol Cardiothorac Imaging 2020;2:e200019. [PMID: 33778541 DOI: 10.1148/ryct.2020200019] [Reference Citation Analysis]
391 Taha MB, Avenatti E, Li DS, Ohonba T, Cainzos-Achirica M, Patel KV, Nasir K. A Checklist Approach for Enhanced Outpatient Guideline-Directed Management in the Secondary Prevention of Atherosclerotic Cardiovascular Disease. Methodist Debakey Cardiovasc J 2021;17:79-86. [PMID: 34824684 DOI: 10.14797/mdcvj.907] [Reference Citation Analysis]
392 Jia X, Al Rifai M, Hussain A, Martin S, Agarwala A, Virani SS. Highlights from Studies in Cardiovascular Disease Prevention Presented at the Digital 2020 European Society of Cardiology Congress: Prevention Is Alive and Well. Curr Atheroscler Rep 2020;22:72. [PMID: 33009957 DOI: 10.1007/s11883-020-00895-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
393 Nakama C, Kadowaki T, Choo J, El-Saed A, Kadota A, Willcox BJ, Fujiyoshi A, Shin C, Leader JK, Miura K, Masaki K, Ueshima H, Kuller LH, Bon J, Sekikawa A. Cross-sectional association of bone mineral density with coronary artery calcification in an international multi-ethnic population-based cohort of men aged 40-49: ERA JUMP study. Int J Cardiol Heart Vasc 2020;30:100618. [PMID: 32904231 DOI: 10.1016/j.ijcha.2020.100618] [Reference Citation Analysis]
394 Chow ALS, Alhassani SD, Crean AM, Small GR. Coronary CT Angiography Guided Medical Therapy in Subclinical Atherosclerosis. J Clin Med 2021;10:625. [PMID: 33562179 DOI: 10.3390/jcm10040625] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
395 Davis JW, Weller SC. Intensity of statin therapy and muscle symptoms: a network meta-analysis of 153 000 patients. BMJ Open 2021;11:e043714. [PMID: 34130955 DOI: 10.1136/bmjopen-2020-043714] [Reference Citation Analysis]
396 Kim EJ, Wierzbicki AS. Cardiovascular prevention: Frontiers in lipid guidelines. Clin Med (Lond) 2020;20:36-42. [PMID: 31941730 DOI: 10.7861/clinmed.cme.20.1.2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
397 Severance LM, Carter H, Contijoch FJ, McVeigh ER. Targeted Coronary Artery Calcium Screening in High-Risk Younger Individuals Using Consumer Genetic Screening Results. JACC Cardiovasc Imaging 2021;14:1398-406. [PMID: 33454274 DOI: 10.1016/j.jcmg.2020.11.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]